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Abstract 
The goal of this study is to provide a deeper insight into how metals bind intrinsically disordered 
proteins (IDPs) by taking zinc binding to prothymosin-alpha as a case study. The involvement of 
metals in several diseases caused by (IDPs) has been noted long ago (Cu binding of α-synuclein 
in Parkinsons disease, prion aggregation due to Cu in madcow disease. etc.). However, there is 
still a lack of understanding of how metal binds IDPs. A deeper insight into metal binding by 
IDPs is essential for a full understanding of a proteome and to pave a way for drug development. 
Prothymosin-alpha (Protα) is an acidic, natively unfolded, and highly conserved protein located 
mostly in the nucleus of eukaryotic cells. It consists of 110 amino acids out of which 53 residues 
are aspartic (D) and glutamic (E) acids thus it is highly acidic. The exact biological role of the 
protein is unknown. However, it has been shown to be involved in cell proliferation, chromatin 
remodeling, antiapoptotic activity etc. One of the most interesting characteristics of Protα is its 
ability to bind metal cations like Ca
2+
, Mg
2+
, Mn
2+
, Zn
2+
, Al
2+
. In the background of all these 
cations, Protα selectively interacts with Zn2+ and undergoes a structural change plus the 
interactions of the protein with its binding partners are enhanced in the presence of Zn
2+
. These 
features underline the importance of Zn
2+
 binding in Protα.  
Very little information is available about Zn
2+
 binding to Protα. A recent NMR study has shown 
that the 48-110 segment of Protα is the Zn2+ binding region of the protein. Although the 48-110 
 
 
 
 
region is shown to be the Zn
2+
 binding region, the central 50-89 segment, where most of the Zn
2+
 
binding residues are located in the protein, was used for all the studies here.  
To aid in the synthesis, purification, and characterization of highly negatively charged sequences 
like Protα(50-89)N50W new amino acid derivatives, 4-pyridylmethyl protected glutamic and 
aspartic acids were developed and their application was tested. Subsequently a circular dichroism 
(CD) spectroscopic study on Protα(50-89)N50W revealed that the peptide, like the full length 
protein, undergoes a structural change in the presence of Zn
2+
 and both the full protein and the 
peptide were saturated at 75 eq of Zn
2+
 indicating that the majority of Zn added binds in this 
region. The above study had also shown that selective binding of Zn
2+
 by Protα(50-89)N50W is 
due to sequence specificity and not solely because of electrostatic interactions between Protα(50-
89)N50W and Zn
2+
. Further the CD and differential scanning calorimetry (DSC) studies have 
shown that Protα(50-89)N50W undergoes a structural change similar to an alpha helix when 
heated from 20-80 
o
C.  
To set the stage for determining the specific glutamic and aspartic residues in Prot that act as 
ligands for Zn
2+
, a  proof of principle for spin inversion recovery experiments has been provided 
using Zn
2+
 binding to EDTA as a model. This idea can further be extended to Protα(50-
89)N50W to understand if Zn
2+
 binds to a specific set of residues or if several degenerate binding 
sites exist.  
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Chapter 1 Introduction 
Section 1.1 Natively Unfolded Proteins 
The term “natively unfolded” protein is used to refer proteins at neutral pH that have been 
experimentally shown or predicted to lack ordered structure (1). 
Natively unfolded proteins are classified into two categories, those that are completely 
disordered throughout their length (often called as natively unfolded proteins, NUP) and those 
that contain a disordered region of at least 30-50 consecutive residues. The latter are called 
intrinsically disordered proteins (IDP) (1, 2). 
Various terms have been used to describe NUP’s or IDP’s, including: flexible (3) mobile (4), 
partially folded, natively denatured (5), natively unfolded (6) intrinsically unstructured (7), 
rheomorphic (8), natively disordered (9), and intrinsically disordered (2, 18). None of these terms 
or combinations is completely appropriate. Flexible, mobile, and partially folded have the 
longest histories and most extensive use; however, all three of these eight terms have been 
borrowed from protein folding or crystallography and are not directly related to the biologically 
active proteins that normally exist as structural ensembles. For example, partially folded is often 
used to describe transient intermediates involved in protein folding. With regard to the term 
natively, it is difficult to know whether a protein is in its native state. Even when under 
apparently physiological conditions, a protein might fail to acquire a specific 3-D structure due 
to the absence of a critical ligand or because the crowded conditions inside the cell are needed to 
promote folding. Because of such uncertainties, “intrinsically” is often chosen over “natively” 
(9). Unfolded and denatured are often used interchangeably, so the oxymoron “natively 
denatured” has a certain appeal but has not gained significant usage. Unfolded and unstructured 
 
 
  
 
 
2 
 
both imply lack of backbone organization, but natively disordered proteins often have regions of 
secondary structure, sometimes transient and sometimes persistent.  
The term “intrinsically disordered proteins” (IDP) will be used throughout the document to refer 
to proteins that contain a disordered region of at least 30-50 consecutive residues.  
 
Prediction of disorder in proteins 
Using predictor programs it was determined that more than one-third of the proteins are 
disordered (10). Amino acid analysis of approximately 100 natively unfolded proteins has led to 
the prediction that disorder is related to protein sequence (11). In an attempt to understand the 
relationship between sequence and disorder, Dunker and coauthors have developed several 
neuronal network predictors. They assumed that if a protein structure has evolved to have a 
functional disordered state then a propensity for disorder might be predictable from its amino 
acid sequence and composition. By analyzing many proteins (~100) that lack secondary structure 
it was found that the common features include lack of sequence complexity, have high net 
charge/low hydrophobicity, and large hydrodynamic volume. Knowing about these three features 
gives predictive power.  
1. Natively unfolded proteins are analyzed for sequence complexity. Sequences of natively 
unfolded proteins/regions may be essentially degenerate (contain same amino acid/set of 
amino acids repeatedly) and be less complex (12).  
2. The presence of high net charge and low hydrophobicity is another feature of disorder. It 
is an important prerequisite for the absence of compact structure in proteins under 
physiological conditions. Figure 1.1 shows comparison of mean hydrophobicity and 
mean net charge for a set of 275 folded and 102 intrinsically disordered proteins. The line 
 
 
3 
 
stands as a barrier between hydrophobicity of folded and unfolded proteins. Disordered 
proteins showed less hydrophobicity than the folded ones. 
 
Figure 1.1: Comparison of the mean hydrophobicity and the mean net charge for a set of 275 
folded (black circles) and 102 natively unfolded proteins (open circles) (12). 
 
3. Hydrodynamic volume for natively unfolded proteins was calculated from the Stokes 
equation.  
  
  
     
 
Measuring the diffusion coefficient (D) of proteins in solution allows one to calculate the 
hydrodynamic radius by using stokes equation. IDP’s are found to have higher 
hydrodynamic volume compared to folded proteins.  
Apart from the conformational analysis studies several predictor programs have evolved to study 
protein disorder (13). Sequence disorder of a protein can be predicted using computational 
H = hydrophobicity 
R = net charge 
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methods. The first predictor program of ID regions was called as Neuronal Network Predictor. It 
was reported in 1997 (14). The program works on local amino acid composition, hydropathy, and 
flexibility bases. The predictive model was later extended to the VLXT predictor (15) by a 
descriptive prefix, Predictor of Natural Disordered Regions (PONDR), giving PONDR VLXT.  
In 2000, it was noticed that natively unfolded proteins can be separated from ordered proteins by 
considering their average net charge and hydropathy (16). This observation led to the 
development of a simple binary classifier, the charge hydropathy plot (CH-plot) (16). The CH-
plot works on the analysis of global sequence composition and classifies the entire protein as 
compact or natively unfolded. Another binary classifier is the cumulative distribution functions 
(CDF) analysis of disorder scores, which separates ordered and disordered sequences based on 
the per-residue disorder score retrieved by PONDR VLXT, and the optimal boundary (17, 18). 
This method summarizes the per-residue predictions by plotting PONDR scores against their 
cumulative frequency, which allows ordered and disordered proteins to be distinguished based 
on the distribution of prediction scores. Later, more sophisticated methods based on various 
statistical and machine learning techniques were published (19, 20). 
 
Biophysical characterization of IDPs 
The demand for structural and molecular dynamics data of IDPs is growing. A need for deeper 
insight into the dynamics of IDP’s necessitated the development of new experimental techniques 
(21). Additionally, computational techniques have been invented to interpret experimental data to 
obtain accurate structural models of IDPs. Algorithms such as flexible-meccano (22) have been 
created specifically for the generation of ensembles of conformations, the form of representation 
usually chosen for the molecular description of IDPs (23, 24).  
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Although several experimental techniques and computational analyses that provide insight into 
the dynamics of IDP’s have been developed to obtain the structural models of proteins, NMR 
stands as the first technique to probe protein structure propensities and dynamics. However, in 
the case of IDP’s the lack of dispersion of proton resonances and severe signal-overlap causes 
problems in NMR of IDPs, while intramolecular motions cause slower relaxation rates and allow 
the acquisition of spectra with narrow lines (25, 26, 27). Advances in methodology, sample 
preparation techniques, labeling schemes, and NMR technology helped to overcome the problem 
of signal-overlap, thus enabling the study of more, larger IDPs by NMR spectroscopy (26). 
However, intrinsically disordered regions are often part of large multi-domain proteins, 
connecting well-structured enzymatic domains and should be investigated in context with the 
super tertiary structure of the protein (27). In two recent studies, the super tertiary structure of the 
membrane associated guanylate kinase (MAGuK) PSD-95, a large scaffold protein with a 
number of disordered linkers connecting protein-binding domains, was resolved by employing 
single molecule FRET (fluorescence resonance energy transfer) (28), and a combination of NMR 
and small angle X-ray scattering (SAXS) (29). This underlines the importance of complementary 
approaches with other biophysical techniques to obtain a complete picture of the complicated 
conformational ensembles.  
Experimental determination of lack of appreciable secondary structure requires combination of 
different biophysical methods such as CD, NMR, dynamic light scattering (to get the 
hydrodynamic radius), and SAXS. If the protein exhibits certain spectral features (random coil 
CD, large hydrodynamic volume, lacks a maximum in the Kratky plot) it can be classified as an 
IDP.  
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1. Secondary structure: Unfolded polypeptide chains are characterized by very specific shapes 
of their far-UV CD spectrum, with an intensive minimum in the vicinity of 200 nm and an 
ellipticity close to zero in the vicinity of 222 nm. A random coil-like shape of far-UV CD 
spectrum has been reported for ∼100 proteins, which is almost threefold larger than the 
number of proteins shown to be unfolded in accordance with their hydrodynamic 
dimensions (11). The far-UV CD spectra of α-synuclein, prothymosin-α, phosphodiesterase 
γ-subunit and the caldesmon 636-771 fragment are shown in Figure 1.2 as typical 
representatives of the family of natively unfolded proteins. One can see that these proteins 
(as well as all other intrinsically unstructured proteins, whose far-UV CD spectra were 
studied) possess distinctive far-UV CD spectra with characteristic deep minima in the 
vicinity of 200 nm, and relatively low molar ellipticity at 220 nm. The analysis of these 
spectra indicates low content of ordered secondary structure (α-helices and β-sheets). This is 
also confirmed by the Fourier-transform infrared (FTIR) analysis of secondary structure 
composition of natively unfolded proteins, such as tau protein (5), α-synuclein (6, 30), casein 
(31), and cAMP-dependent protein kinase inhibitor (32). Importantly, even the caldesmon 
636-771 fragment, which was shown to have hydrodynamic properties typical of the pre-
molten globule possesses far-UV CD characteristic of essentially disordered polypeptide 
chain.  
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Figure 1.2: Far-UV CD spectra of intrinsically unordered proteins, α-synuclein (1), 
prothymosin-α (2), caldesmon 636-771 fragment (3) and phosphodiesterase c-subunit (4) (11).  
 
2. Another very important structural parameter to classify a protein as folded or unfolded 
protein is the degree of globularization that reflects the presence or absence of tightly 
packed core in the protein molecule. This information could be extracted from the analysis 
of small angle X-ray scattering (SAXS) data (Kratky plot), whose shape is sensitive to the 
conformational state of the scattering protein molecules (33, 34). It has been shown that a 
scattering curve in the Kratky plot has a characteristic maximum when the globular protein 
is in the native state or in the molten globule state (i.e. has a globular structure). If a protein 
is completely unfolded or in a pre-molten globule conformation, such a maximum will be 
absent on the respective scattering curve (33, 35, 36). Figure 1.3 compares the Kratky plots 
of three natively unfolded proteins (α-synuclein, prothymosin-α and the caldesmon 636-771 
fragment) with that of the rigid globular protein SNase. One can see that intrinsically 
disordered proteins give Kratky plots without maxima typical of folded conformations of 
 
 
8 
 
globular proteins. Thus, these three natively unfolded proteins are characterized by the 
absence of globular structure, or, in other words, they do not have a tightly packed core 
under physiological conditions in vitro.  
 
Figure 1.3: Kratky plots of SAXS data for natively unfolded a-synuclein (1), prothymosin-α (2) 
and caldesmon 636-771 fragment (3). The Kratky plot of native globular SNase is shown for 
comparison (4, 11). 
 
Structure function paradigm 
It is widely believed that the function of a protein is related to its 3D structure. Though the 
presence of unfolded proteins or unfolded segments in proteins has been known, they were not a 
focus of much research until a key publication by Wright and Dyson came out in 1999 (7). 
Wright and Dyson have made a comprehensive survey of experimental works on proteins, 
including NMR measurements revealing that various proteins interact with other proteins via 
intrinsically disordered (ID) regions, thus bringing into light the importance of natively unfolded 
proteins. Using conformational analysis and several prediction programs approximately 100 
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unfolded proteins have been analyzed experimentally (11). In short, prediction of disorder has 
given an alternative view to the structure-function paradigm.  
Here we explore the distinction between the standard and alternative view of structure-function 
paradigm. The standard structure-function paradigm arose from the study of enzymes. The 
original lock and key proposal (9) was based on distinctive substrate recognition by an enzyme. 
Enzymes bring substrates together in an optimal orientation to facilitate the making or breaking 
of chemical bonds through stabilization of the transition state. To achieve this, the enzyme must 
possess a unique active site where the substrates bind. The positioning of the key residues that 
form the active site is critical to the proper functioning of the enzyme. The active site is usually 
a 3D cleft in the protein that exists as a result of the overall 3D structure of the protein. Thus, in 
short, the evolution of ordered structure in proteins was likely reinforced by or directly resulted 
from the importance of enzyme catalysis. 
The functional importance of being disordered has been extensively analysed. IDPs are not well 
suited to enzymatic activity as they do not have the propensity to form structures which are 
required to form active sites. For most of the natively disordered proteins studied (37, 38), the 
function of the disorder is for signalling, regulation. The majority of disordered proteins undergo 
disorder to order transition upon binding its partner such as a metal or another protein.  The free 
energy required to bring about the disorder to order transition takes away from the interfacial, 
contact free energy, with the net result that a highly specific interaction can be combined with a 
low net free energy of association (2). In addition, a disordered protein can have multiple partners 
and can associate with several targets.  
Given the above information, a new protein structure-function paradigm was proposed (9). 
Simply put, a two-pathway paradigm, with sequence to 3-D structure to function for catalysis 
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(Figure 1.4A) and sequence to native disorder to function for signalling and regulation (Figure 
1.4B).  
                                                                                                                  
 
 
 
 
 
 
                                    
 
 
 
 
 
Figure 1.4: A) Protein structure-function paradigm showing A) folded protein to function 
(catalysis) B) Alternative view (IDP to signaling and regulation) 
 
The next important topic of interest is metal binding of intrinsically disordered proteins. 
Correlating the facts that one-third of the proteins are disordered and more than one-third of the 
all the proteins require metal co-factors to carry out their function (39, 40) raises in the question 
about the extent of overlap of IDPs with metalloproteins. All these sum up as key reasons to 
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study the importance of metals in the functioning of natively unfolded proteins by biophysically 
characterizing metallo-IDPs.  
Metal ions in folded proteins versus intrinsically disordered proteins 
In folded proteins metals are known to act as cofactors. For example, heme proteins, which 
contain a porphyrin ring, coordinate to iron and this coordination is necessary for the transport of 
oxygen. The binding of metal ions by proteins can stabilize the structure, as is Zinc finger 
proteins, for example metal ion-binding proteins increase the structural stability and serve as a 
cross-linking agent to bring reactive groups into the correct orientation for reaction. They can 
serve as redox centers for catalysis (e.g., haemiron centers) or as electrophilic reactants in 
catalysis (20). Metals can also play a regulatory role in proteins (41). 
In IDP’s metals are mostly known to induce a structural change. For example, prothymosin-
alpha is known to attain a compact conformation in the presence of Zn
2+
. Zn
2+
 binding induces 
partial folding of proteins such as thymosin α1 (42), Prothymosin-α (43) human sperm 
Protamines P2 and P3 (Gatewood et al. 1996), and phosphodiesterase γ-subunit (11). Human α-
synuclein which is also a natively unfolded protein was also shown to be partially folded in the 
presence of several divalent and trivalent metal ions. Unlike the metal bound folded proteins 
very little information is known about metallo-IDPs. For example, prothymosin-α is known to 
bind Zn
2+
 but the importance of Zn
2+
 binding in prothymosin-α’s function is yet to be revealed. 
The protein α-synuclein is known to bind metal ions but the role of the protein interaction with 
the metal in Parkinsons disease is still under research (44). 
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Why should we study IDP’s and metal binding in IDP’s? 
Despite the lack of a stable secondary and tertiary structure, IDPs play important roles in critical, 
mostly regulatory, cellular functions such as differentiation, transcription regulation, DNA 
condensation, mRNA processing, and apoptosis (27, 45). These functions are frequently 
modulated by post-translational modification such as phosphorylation or glycosylation. 
Numerous IDPs have been connected to diseases; examples include α-synuclein in Parkinson’s, 
tau protein in Alzheimer’s, or the role of tumor suppressor p53 in cancer formation (46). The 
biological importance of IDPs becomes evident with the severity of the pathological conditions 
associated with malfunctions of IDPs. Due to their involvement in disease, IDPs became of 
interest for drug discovery, and strategies to create molecules that would inhibit disorder-based 
interactions of IDPs have been developed (25). Depending on the pathogenesis, drugs have been 
designed to either inhibit binding, like in the case of the oncoprotein c-Myc (47), or to block 
amyloid aggregation, the key event in neurodegenerative disease (48). But regardless of the 
desired molecular effect of the drug, atomic-scale structural characterization of the target allows 
rational drug design and the discovery of more effective treatments (25, 48). Therefore, 
understanding the molecular features of IDP’s and biophysical characterization of metal binding 
to these proteins has gained attention.  
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1.2 General Introduction about Prothymosin-α (Protα) 
Numerous examples of natively unfolded proteins and protein domains exist (7, 30, 49) and 
prothymosin alpha (Protα) is one among them (50, 51). It is a highly conserved protein in 
eukaryotes. The highly conserved nature of the protein suggests the essential role for this protein 
at cellular level (52). It is present in numerous tissues in mammals. It is synthesized in cytoplasm 
and migrates to the nucleus (53).  
It is a highly acidic protein due to the fact that 52% of the residues are aspartic and glutamic 
acids. Most of the acidic residues are clustered in the central region (Figure 1.5).  
 
S D A A V D T S S E I T T K D L K E K K E V V E E A E N G R D A P A N G N A E N E E N 
G E Q E A D N E V D E E E E E G G E E E E E E E E G D G E E E D G D E D E E A E S 
A T G K R A A E D D E D D D V D T K K Q K T D E D D 
Figure 1.5: Amino acid sequence of human prothymosin-alpha. The sequence is highly acidic 
with most of the acidic residues (glutamic and aspartic acids) located in the central segment of 
the sequence. 
 
Protα is highly hydrophilic in nature with a low isoelectric point (pI = 3.55) (54).  The protein 
does not contain aromatic or sulfur containing amino acids and therefore does not absorb light at 
280 nm. It has four valines and one leucine while the rest of the residues are polar or small like 
glycine or alanine. 
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Posttranslational modifications of Protα have been reported including unusual phoshorylation at 
glutamic acid residues and proteolytic cleavage of the N-terminus by lysosomal asparaginyl 
endopeptidase producing a 28 amino acid bioactive peptide called thymosin-α 1 (Tα1) (55). 
Protα is classified as a Thymosin with nuclear localization sequence (56). Three stretches of basic 
residues are located in the sequence. The motif KEKKE located at the N-terminus apparently 
does not possess nuclear import activity (57), whereas the motifs KR and KKQK located in the 
C-terminus of the proteins are potent signals for nuclear localization (58). 
At pH 7.5, by using a combination different techniques discussed in section 1.1 Protα has been 
found to have no regular secondary structure, and its hydrodynamic dimensions are typical of a 
random coil (43). Through the use of circular dichrosim (CD) it has been shown that Protα in 
solution adopts a random coil like conformation (59). The structural properties and 
conformational stability of recombinant human prothymosin-α were characterized at neutral and 
acidic pH by gel filtration, small angle X-ray scattering (SAXS), and ANS fluorescence. At 
neutral pH recombinant human Protα possesses all the properties of the unfolded state, whereas 
lowering the pH results in the transformation of the protein into a partially folded conformation 
(57, 58, 59, 9). The topic will be elaborated in section 1.4. 
The protein is acetylated at the N-terminus to protect against proteolytic degradation. The central 
region of Protα carries most of the acidic residues and is thought to be a metal binding region 
capable of binding zinc (60). Metal binding of this protein will be discussed in later sections. 
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1.3 Biological role of Protα  
Since the discovery of Protα, its exact biological role has been obscure (61). It is a small acidic 
protein that has been implicated in a number of diverse biological activities. At first Protα was 
isolated from rat thymus and considered as a thymic factor with a hormone-like role in the 
maturation of T-lymphocytes (62). It has been reported to be involved in numerous activities 
including cell proliferation (52), translocation, chromatin remodeling (63), DNA packaging. It is 
also known to have an immunomodulatory role (64).   
It has been shown that expression of Protα is elevated in proliferating tissues (63, 61, 65) and over 
expression of Protα results in shortening of G1 phase of the cell cycle. These findings indicate 
that Protα must be a limiting factor necessary for the progression of cell cycle (63, 73). Because 
of its role in cell cycle progression it has been used as a proliferation marker in various tumoral 
processes. Malignant tissues show higher levels of Protα expression compared to healthy tissues 
surrounding the area (66, 67). Due to this finding it has been established as a marker for breast 
cancer (68). Protα has been of prognostic value as it is associated with factors that describe the 
metastatic potential of the tumor and the risk of death (67). This protein also serves as a marker 
for hepatocarcinoma.  
The location of Protα in the cell nucleus, its acidic nature which resembles some 
chromatin/chromosomal proteins, and its structural similarity to nucleoplasmin, a chromatin 
remodeling protein in Xenopus, suggests that Protα is involved in chromatin organization (53). 
Further, the interaction of Protα with histone H1 in vitro also supports this idea. 
Protα participates in DNA packaging (51, 69). It is involved in translocation of STAT3 which is a 
transcription factor that dimerizes and translocates into the nucleus to activate transcription of 
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IFN-stimulated genes. The nuclear targeting of Protα to translocate STAT3 is mediated by a 
bipartite nuclear localization signal (KR and KKQK) positioned close to the C-terminus (70). 
(Figure 1.5) 
Immunomodulatory Role: 
As mentioned above, Protα has an immunomodulatory role. It has been recently discovered that 
exogenous Protα acts as anti-HIV agent. CD8+ T lymphocyte cells secrete soluble molecules 
capable of inhibiting HIV-1 replication in vitro and Protα was identified in fractions of CD8+ T 
cell secretions. The protein is known to suppress HIV replication by type 1 interferon (IFN) 
induction (64, 71-73). In an effort to identify the anti-HIV domain(s) of Protα it was found that 
the central segment (50-89) of the protein has significant anti- HIV activity (71). Interestingly the 
same 50-89 region of the protein is known as the metal binding region in Protα. This topic will 
be further discussed in detail in section 1.4 and 1.5. 
Protα is shown to interact with mutant Huntington protein. Huntington disease (HD), a fatal 
neurodegenerative disorder, is caused by a lengthening of the polyglutamine tract in the 
huntington (Htt) protein (74). Over expression of Protα remarkably reduced mHtt-induced 
cytotoxicity in both non-neuronal and neuronal cell models expressing N-terminal mHtt 
fragments, whereas knockdown of Protα expression in the cells enhanced mHtt caused cell death. 
Deletion of the central acidic domain of Protα abolished not only its interaction with mHtt but 
also its protective effect on mHtt-caused cytotoxicity (74).  
Interaction with binding partners 
Protα is known to interact with REV of HIV-1 and CREB (70, 75). Rev stands for Regulator of 
expression of virion proteins. It shuttles between the nucleus and the cytoplasm and harbors both 
 
 
17 
 
a Nuclear Localization Signal (NLS) and a Nuclear Export Signal (NES) (76). The function of 
this protein is nuclear export of unspliced RNA of HIV-1. Protα is known to bind the NES 
domain of REV through N-terminal lysine residues. This interaction is shown to significantly 
increase in the presence of zinc (75). Zinc bound Protα is partially folded resulting in enhanced 
interaction with REV (60, 75). 
HIV infected patients have zinc deficiency and decreased intracellular concentration of Protα (77, 
78). The fact that Zn
2+
 binding region of the protein falls in the anti-HIV domain of the protein 
(50-89 segment) and the enhancement of the interaction of Protα to the NES region of REV in 
the presence of Zn
2+
, leads to the speculation that down regulation of zinc and Protα in HIV-1 
infected cells is one of the viral defense mechanisms to release REV from bound Protα and carry 
out its function for HIV replication (64, 79). An elucidation of the function of Protα and its Zn2+  
binding characteristics opens new possibilities for the understanding of role of the protein in 
several biological pathways.  
Protα interacts with a cellular transcription factor, CREB. CREB stands for cAMP response 
element binding protein. Direct evidence for physical interaction between Protα and CREB was 
obtained by glutathione pull down experiments. Protα interacts with the versatile co-activator of 
transcription CBP (CREB binding partner) both in vivo and in vitro and stimulates gene 
transcription. The site of interaction was mapped within the N-terminal domain of CBP (residues 
1–771) and a region of Protα composed of two polyglutamic acid stretches. This binding could 
be due to the specific sequence characteristics of this acidic domain of Protα and/or its local 
conformation. The interaction of Protα with the CREB protein and its ability to stimulate 
transcription suggests an important role for this acidic polypeptide in gene expression (70).  
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1.4 Metal binding characteristics of Prothymosin-α 
Several investigations on the structural properties of Protα have been carried out by means of 
NMR, CD, SAXS, gel filtration, ANS fluorescene (43, 60, 75). The studies have shown that at 
physiological pH the protein is in a random coil like conformation. However, the structure of 
Protα has been shown to be influenced by environmental factors like pH and counter ions (59). 
At highly acidic pH Protα is shown to be transformed into a partially folded conformation known 
as pre-molten globule state (80). Zn2+ binding of the protein at physiological pH has been also 
shown to induce a change in the secondary structure of Protα.  
There is no literature information showing temperature effects on Protα. However, the effect of 
temperature on other natively unfolded proteins, like Protα, has shown that the proteins undergo 
a structural change adopting a partial α-helix conformation. The effect of temperature 
specifically on Protα will be discussed in Chapter 3.  
Protα is known to bind several metal cations like Ca2+, Mg2+, Mn2+, Zn2+, etc. Among all these 
metal cations, only Zn
2+
 binding induces a structural change in the protein.  
At physiological pH Protα is unfolded due to the strong electrostatic repulsion between acidic 
residues. It was believed that this repulsion could be reduced by the addition of oppositely 
charged ions (43). To test this hypothesis several divalent metal cations like Ca2+, Mg2+, Mn2+, 
Zn
2+
, etc were added to the protein and using CD spectroscopy it was found that the protein 
undergoes a partial change in the secondary structure only upon Zn
2+
 addition (Figure 1.6A). A 
titration plot was constructed by plotting ellipticity versus wavelength which shows the 
saturation behavior (Figure 1.6B) and shows that the protein was saturated at 75 eq of ZnCl2. 
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Figure 1.6: Zn
2+
-induced changes in Protα far UV CD spectrum. A) Far UV CD spectrum of the 
full length Protα at different Zn2+ concentrations.  B) The Zn2+ dependence of the [θ]222 value 
(43).  
 
However, this structural change occurred specifically in the presence of Zn
2+
. The fact that no 
other positively charged divalent metal cation except Zn
2+
 could induce the structural change 
suggested that Zn
2+
 binding may be important for the protein’s function. 
A 
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The same study using SAXS looked at the radius of gyration (Rg) of native and metal bound 
Protα. The lower the Rg value the more structured the protein. The Rg value of the protein at low 
pH or with ZnCl2 decreased reflecting considerable compaction of the protein. X-ray scattering 
also has shown that acidification or addition of Zn
2+
 to Protα induced a more ordered 
conformation.  
Chichkova et al. has used equilibrium dialysis to show the binding of Protα to Zn2+ in the 
presence of other ionic competitors (75). It was found that the binding is selective for Zn
2+
 and 
not just taking place due to electrostatic interactions. The parameters of zinc binding by Protα 
were determined using Zn
2+
 at different concentrations. Two buffer systems were used in this 
study, one with “low ionic strength” and another with “high ionic strength”. The results show 
that under low ionic conditions Protα binds up to 13 zinc ions per one protein molecule with an 
apparent KD = 40 µM. Under high ionic strength, Protα was found to bind 5 Zn
2+
 with an 
apparent KD = 230 µM. The data suggests that Protα has several Zn
2+
 binding sites which differ 
in affinities based on the ionic conditions. 
More info about the metal binding region of Protα have been revealed by chemical shift mapping 
by Yi et al. (60). This study used NMR spectroscopy and ESI-MS to characterize the structure 
and dynamics of Protα and its interactions with zinc ions.  
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Figure 1.7: Reference-Independent      
      (   ) 
    secondary chemical shifts of (A) 
Protα (B) Protα in the presence of 6 mM of Zn2+. Positive and negative strands indicate the 
helical and β-strand propensities, respectively. The shaded box indicates the glutamic acid rich 
region, which contains 20 unassigned acidic amino acid residues (60).  
 
The backbone resonance assignments of 
13
C/
15
N-labeled Protα were assigned by collecting a set 
of five heteronuclear triple resonance experiments, HNCACB, CBCA(CO)NH, CCCTOCSY, 
HNCACO, and HNCO (81). For zinc titration experiments, 1H-15N HSQC spectra of 0.1 mM 
15
N-labeled Protα were recorded in the presence of different concentrations of ZnCl2 (0-3 mM). 
It has revealed that the protein binds Zn
2+
 via its C-terminal residues (48-110). The results from 
these studies indicate that Zn
2+
 binding to the central region have a significant influence on the 
dynamics of the target binding sites of Protα. The above Figure 1.7 represents reference 
independent chemical shifts of each residue in Protα before and after the addition of zinc. The 
central Glu rich region was left unassigned, because of the homogeneity in the sequence.  
Pulsed field gradient experiments were performed to obtain the hydrodynamic radius of Protα. 
These experiments helped to study overall compactness of Protα upon Zn2+ binding. The 
B A 
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hydrodynamics radius, Rh, of Zn
2+
 titrated Protα decreased compared to the Rh of native Protα. 
This once again confirms transition of Protα to more compact conformation upon metal binding.  
Backbone dynamics of Protα were reexamined using relaxation measurements and steady state 
NOE experiments. In the absence of Zn
2+
 the measured relaxation rate (R1) (defined as the rate at 
which the molecule relaxes) values of Protα fell in the range 1.2-2.0 s-1. Figure 1.8 shows that 
upon addition of 6mM Zn
2+
 there was a significant increase in the R1 values of residues 48-82 
suggesting that it is the Zn
2+
 binding region.   
The steady state 
1
H-
15
N NOE is sensitive to fast internal motions of the backbone, providing a 
good indicator of protein mobility on the picosecond-nanosecond time scale. For a folded protein 
with a molecular weight corresponding to that of Protα the NOE values with restricted mobility 
would be expected to be around 0.8 (82). A lower NOE value indicates increased local flexibility. 
For native Protα all the NOE values were negative indicating a highly unstructured nature of the 
protein (Figure 1.9). With the addition of Zn
2+
 the NOE values became positive for residues 48-
110 indicating a restricted mobility of the residues upon Zn
2+
 addition. 
 
 
Figure 1.8: Backbone 
15
N longitudinal relaxation measurements of Protα. The experiments were 
carried out in the presence (blue) and absence (red) of 6 mM ZnCl2 (60). 
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Figure 1.9: Backbone steady-state 
1
H-
15
N NOE of Protα. The experiments were carried out in 
the presence (blue) and absence (red) of 6 mM ZnCl2 (60).  
 
Influence of Zn
2+
 on binding of Protα with its partners 
Protα has many binding partners. It interacts with REV of HIV-1 and Histone H1 (83, 84). Rev 
stands for Regulator of expression of virion proteins. It shuttles between the nucleus and the 
cytoplasm and harbors both a Nuclear Localization Signal (NLS) and a Nuclear Export Signal 
(NES) (76, 85). The function of this protein is nuclear export of unspliced RNA of HIV-1. Protα 
is known to bind the NES domain of REV through N-terminal lysine residues. The effect of Zn
2+
 
on the binding of Protα to REV was observed (76). Both in the presence and absence of Zn2+, 
Protα is shown to interact with REV. However, the interaction of Protα with REV was 
significantly enhanced in the presence of Zn
2+ 
as determined by a ‘pull-down’ assay. 32P-labeled 
Protα was incubated with Ig-G sepharose immobilized zz-rev and zz (1 µg of the corresponding 
protein per sample) in the binding buffer in the presence and absence of 10 µM Zn
2+
. The bound 
protein was eluted by SDS containing buffer and analyzed by 12% PAGE followed by 
autoradiography. The KD value is estimated to be 1 µM for zinc binding by the Rev+Protα 
complex. 
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Figure 1.10: Protα binding to REV of HIV-1 is Zn2+ dependent (74, 75, 3). ‘Input’(lane 1), the 
amount of [
32
P]Protα added to each sample. 1:10 and 1:100 denote 10-fold and 100-fold dilution 
of the [
32
P]Protα with unlabelled Protα lacking artificially added sequences prior to incubation. 
The effect of divalent cations on the interaction of Protα with isolated NES region of Rev was 
also assayed, using a pull-down technique to understand the influence of metal cations. Both in 
the absence and presence of varying concentrations of Ca
2+
 and Mg
2+
 ions a barely detectable 
binding of Protα to NES was observed. However, in the presence of Zn2+ the interaction of Protα 
with NES of REV was enhanced. The NES+Protα complex formed in the presence of Zn2+ ions 
appeared to be unstable and could be dissociated easily. 
 
 
 
25 
 
 
Figure 1.11: Zn
2+
 promotes Protα binding to the NES region of REV (75) 
 
More characteristics of the Zn
2+
 and Protα+REV complex have come to light. HIV infected 
patients have zinc deficiency and decreased intracellular concentration of Protα (77, 78). The fact 
that Protα binds NES region of REV, enhancing the interaction in the presence of zinc, leads to 
the speculation that down regulation of zinc and Protα in HIV-1 infected cells is one of the viral 
defense mechanisms to release REV from bound Protα and carry out its function for HIV 
replication (64, 79). Thus, a detailed understanding of Zn2+ binding sites in Protα and further 
studying of binding of the Zn
2+
 to Protα+NES of REV is highly essential. 
Protα does not share homology with any of the well characterized zinc binding proteins such as 
zinc fingers or superoxide dismutase. It does not have the most common zinc binding amino 
acids such as histidine and cysteine, which means that the Zn
2+
 binding motif is probably unique 
and might reveal an answer to how proteins that lack cysteine and histidine bind Zn
2+
. It might 
also provide insight into how IDP’s bind metals.  
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Section 1.5 Research goals and overview of research strategy 
The goal of this project is to investigate metal binding in natively unfolded proteins, using 
Protα(50-89)N50W as a model peptide. The protein is unusual in that aspartic acid (Asp) and 
glutamic acid (Glu) make up approximately 50% of its 110 residues and it lacks typical metal 
coordinating residues such as histidine (His) and cysteine (Cys). However, it is shown to bind 
several metal cations (Mg
2+
, Zn
2+
, Ca
2+
, etc.) and among all the metal cations only Zn
2+
 could 
induce a structural change in the protein (43). Given the high homogeneity of the sequence, 
further study of Zn
2+
 binding using 2D nuclear magnetic resonance (NMR) studies (which is 
mostly used to study metal binding in proteins) has been a challenge. Due to extensive signal 
overlap NMR had failed to determine which Asp and Glu residues are directly involved in Zn
2+
 
binding
 (60). Further, Zn2+ is a spectroscopically silent metal. Our work using Protα(50-
89)N50W should lay ground work for answering questions like: where is Zn
2+
 binding to Protα 
and how Zn
2+
 binding is affected by varying factors like temperature. We have also examined if 
Zn
2+
 binding is solely due to electrostatic interactions with the highly negatively charged 
sequences or if it is a sequence specific interaction. 
As mentioned in section 1.1 the extent of information known about metal binding in natively 
unfolded proteins is limited. Understanding the Zn
2+
 binding in natively unfolded protein like 
Protα serves as a case study for how IDPs in general may bind metals so we may gain a 
mechanistic understanding of the specific structural and functional roles protein disorder plays 
with regard to metal binding.  
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Aim: To determine if zinc binding to prothymosin-alpha is specific - meaning that a unique set of 
residues provide the coordinating ligands or if many energetically “degenerate” sites exist within 
the central region (Figure 1.12) 
 
Figure 1.12: The protein sequence is displayed as red and green stars, where the red residues 
may serve as ligands, and the blue sphere represents Zn
2+
. Two possibilities are envisioned 
where (1) a single defined set of red residues constitute the Zn
2+
 binding site or (2) numerous 
different combinations of the red residues may constitute a binding site leading to the formation 
of numerous isomers.  
Specific goals: 
1.1 Develop a synthetic method using 4-pyridinemethanol as a side chain protecting group 
on Asp and Glu to improve the synthesis, purification, and characterization of highly 
negatively charged sequence of Protα(50-89)N50W 
Synthesis, purification, and characterization of peptides derived from acidic sequences like Protα 
has been challenging and requires development of a robust synthetic methodology. For all our 
 
 
28 
 
metal binding studies Protα derived peptides were chemically synthesized in order to keep them 
free of any biological extracts. Also, chemical synthesis of peptides is essential for 
13
C labeling 
of peptides for NMR studies (discussed later in NMR studies subsection). So our first focus was 
to development a synthetic approach that allows us to improve the purification and 
characterization of acidic sequences like Protα(50-89)N50W. 
 The Zn
2+
 binding region of Protα has been narrowed down to the central 48-110 segment (59). 
However, the suspected metal binding residues in Protα, Glu and Asp are concentrated in the 
central 50-89 region which made us choose 50-89 as our model peptide for metal binding 
studies. Our synthetic work focuses on the central 50-89 segment of Protα and all the metal 
binding studies use the same segment. 
Considering that the 50-89 sequence contains more than 50% of acidic residues; synthesis, 
purification, and characterization of the sequence is challenging. Our group has been working to 
improve the synthesis, purification, and characterization of the Protα(50-89) segment. During 
synthesis we encountered problems like difficult couplings. Because of the high negative charge, 
reverse phase chromatography and positive ion mode on ESI-MS cannot be used for the 
purification and characterization, respectively, of the synthesized peptides.  
To overcome these problems a strong anion exchange (SAX) purification method was developed 
in our lab (86). The method was successful in purification and characterization of Protα(50-89). 
However, the eluent used in SAX contains 1M NaCl which requires extensive dialysis (6 hrs) of 
the purified sample before injection onto MS for characterization. The main drawback of dialysis 
is it often dilutes the sample and sometimes results in sample loss making signal detection tough 
on ESI-MS. Benzyl ester protected aspartic and glutamic acid were used in the synthesis. The 
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group is acid resistant and is not lost upon treatment with acid. It masks the negative charge of 
aspartic and glutamic acid thus making characterization possibly on positive mode of ESI-MS. 
However, because of the lack of charge on benzyl ester it was found to have its own limitations 
(discussed in detail in section 2.2).  
Here our goal was to develop a synthetic method for the synthesis of negatively charged 
sequences that makes purification and characterization straight forward. In this direction, 4-
pyridinemethanol, which is structurally similar to benzyl alcohol, was used as a side chain 
protecting group on negatively charged Asp ad Glu residues. 4-pyridinemethanol is also acid 
resistant. The advantage of using 4-pyridinemethanol over benzyl ester is that the pyridine ring 
on 4-pyridinemethanol readily accepts a proton and flips the negative charge on carboxylic acids 
of Asp and Glu to a positive charge making the characterization of negatively charged sequences 
possible on positive ion mode of ESI-MS. Whereas the benzyl ester group flips the charge from 
negative to neutral thus making characterization of large peptides challenging using positive 
mode of ESI-MS. The new Asp and Glu derivatives of 4-pyridinemethanol were further applied 
in the synthesis of model peptides to test their efficiency. 
1.2 Determine the structural changes in the central segment of Protα in the presence of 
environmental factors like Zn
2+
 and temperature 
CD studies were carried out to determine the structural changes in the central 50-89 segment of 
Protα in the presence of Zn2+. Protα is classified as a natively unfolded protein (59). In the 
presence of Zn
2+ 
it was found to undergo structural rearrangement (43). The protein is known to 
bind 13 Zn
2+
 ions at low ionic conditions (KD = 40 µM) and 5 Zn
2+
 ions at high ionic conditions 
(KD = 230 µM) (74). Although it is known that the central region of the protein is the metal 
binding region (60), the portion of the protein that undergoes majority of the structural 
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rearrangement has not been determined. We hypothesized that the structural changes in the 
protein occur primarily in the central region. Our first aim was to look for the structural changes 
in the central segment (50-89 segment) of the protein in the presence of Zn
2+
 by using Circular 
Dichroism (CD). CD measurements were made by titrating zinc into the peptide. Spectra 
obtained from these experiments were compared to the CD spectrum of the full length protein 
(43). Next, we studied temperature dependent structural change in Protα(50-89)N50W both in the 
presence and absence of Zn
2+
. A polyglutamic acid sequence was used to study if Zn
2+
 binding in 
Protα is solely due to electrostatic interactions or if there is sequence specificity. 
1.3 Investigate the structural changes in the Protα(50-89)N50W upon thermal denaturation  
using differential scanning calorimetry (DSC) 
A DSC study on Protα(50-89)N50W was carried out to study the conformational stability of the 
peptide in the presence and absence of Zn
2+
. The studies complement the data obtained from CD.  
1.4 Further refine the map of the Zinc binding region of Protα 
The central question addressed here is whether there is a single localized Zn
2+
 binding site or are 
there several degenerate Zn
2+
 binding sites in Protα. 
 An earlier study to map out Zn
2+
 binding region of Protα has shown that 2D NMR had 
difficulties to study Zn
2+
 binding on a residue level (58). The central segment of the protein due 
to high homogeneity is shown to have extreme signal overlap causing trouble to assign amino 
acid chemical shift in this region.  Hence, a new approach is needed as regular NMR fails (signal 
overlap and too much homogeneity). We envision using 
13
C labeled amino acids to study Zn
2+
 
binding by making relaxation measurements. In order to prove this approach works, the way to 
do this is by picking a system we absolutely know binds Zn
2+
 and see if we can detect 
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sufficiently large changes in the T1 values. This was achieved using a simple and inexpensive 
model complex of EDTA and Zn
2+
. Later on the relaxation measurements will be performed on a 
series of 
13
C labeled Protα peptides in the presence and absence of Zn2+. 
As a first step, we developed a 
13
C NMR relaxation method to detect Zn
2+
 binding at the amino 
acid level using the metal-chelator EDTA as a model compound. This has laid down ground 
work for a core set of studies which will involve application of this method to series of Protα 
peptides spanning the metal binding region which contain site-specifically 
13
C labeled residues. 
This system serves as a case study for how IDPs in general may bind metals so we may gain a 
mechanistic understanding of the specific structural and functional roles protein disorder plays 
with regard to metal binding. 
We have chosen ethylenediaminetetraacetic acid (EDTA) as the model compound for the proof-
of-principle 
13
C relaxation studies (Figure 1.13) because of the structural similarities between 
EDTA and carboxylate groups of Glu and Asp. Also, it is known that EDTA is strong chelator of 
Zn (logK = 15.4) (87). The spin-lattice (T1) relaxation times of EDTA with and without Zn
2+
 
were measured. In particular, we focused on the T1 values for the carbonyl carbons as these are 
the closest spin-active nuclei to the Zn
2+
 ion and thus should be most sensitive to its presence or 
absence. To corroborate with the T1 values obtained, the peptide studies will be carried out by 
adding the 
67
Zn isotope to the sample to look for detectable line broadening in the NMR signal. 
The experimental details will be explained in section 3.2. 
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Figure 1.13: A) Structure of EDTA with one of its four carbonyl carbons indicated by red arrow, 
B) Structure of glutamic acid in the context of a peptide sequence. The carbonyl carbon of its 
carboxyl side chain is indicated with a red arrow.  
So far it is estimated that over 30% of proteins catalogued in the protein data base require metal 
ions to perform their biological activities (1). In surveys of select eukaryotic genomes more than 
30% of sequences are predicted to have disordered regions 50 residues or greater (12) and 
hundreds have been classified as intrinsically disordered using biophysical techniques such as 
CD and NMR spectroscopy (12). Thus, there is a great region of overlap here that remains to be 
explored. Ultimately, we seek to gain a mechanistic understanding of the specific structural and 
functional roles protein disorder plays with regard to metal binding. For instance, evidence is 
mounting that IDPs have faster kinetic binding profiles compared to their structured 
counterparts. The coupling of folding with binding by IDPs may lead to a significant reduction in 
binding free-energy barrier and thus an acceleration of the binding process (38). Further, Protα 
lacks typical metal binding residues such as His and Cys. Since a characteristic of many IDPs is 
high net charge this may stimulate the discovery of metal binding regions in proteins that would 
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otherwise go overlooked. Our case study of Protα, with key initial steps outlined here, serves as a 
means to gain insight into the type of issues mentioned above.  
Each of these specific goals will be discussed in detail as a chapter. 
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Chapter 2 
The 4-pyridylmethyl ester as a protecting group for glutamic and aspartic 
acids: ‘flipping’ peptide charge states for characterization by positive ion 
mode ESI-MS 
Section 2.1 Introduction 
The most common methods for the synthesis of peptides are solid-phase peptide synthesis 
(SPPS) and solution phase synthesis. Both the methods can be carried out in a linear fashion or 
by chemical ligation. In linear synthesis each amino acid can be added sequentially, and the 
synthesis can be carried out on an automated synthesizer or in a manual way. The chemical 
ligation method involves fragment condensation of peptide fragments to form the target 
sequence.  
Synthesis, purification and characterization of highly negatively charged sequences have always 
been a challenge (86). Often the standard synthesis method has to be modified to achieve the 
synthesis of the target acidic sequence. A standard linear synthesis requires 20-120 min for the 
coupling of each amino acid depending on the choice of chemistry and synthetic protocol 
followed. However, with acidic sequences the coupling times have to be doubled or tripled to 
achieve acceptable acylation yields (88). Even after careful implementation of these methods the 
long coupling times of the target sequence allow kinetically slower side chain reactions to 
become competitive thus leading to the failure of the acidic sequence synthesis (89, 90). A serious 
problem affecting the fragment condensation method in acidic sequences is the decreasing 
solubility of peptide fragments in organic solvents making the ligation tricky. 
Protα is an acidic protein. Chemically synthesized Protα is more advantageous to use than the 
cell extracted protein for our studies with this protein as the chemically synthesized peptide can 
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be modified at any position in the sequence during the synthesis and it is free of unwanted 
biological components that cell extracted Protα might have.  
Majority of the negative charge is located in the central 50-89 region of Protα which is found to 
be important for its activity (Figure 1.5). The 50-89 segment is found to be essential for metal 
binding (58) and anti-HIV activity (64, 64, 71-73). So, earlier work carried out in our lab on Protα 
focused on the central 50-89 segment. 
Synthesis: 
Several peptides derived from Protα, mainly focused on the 50-89 region were synthesized by 
linear solid phase synthesis on an automated Protein Technologies Inc. PS3 synthesizer or a 
manual CEM microwave synthesizer. 
1.Linear Solid Phase Peptide Synthesis (PS3 Synthesizer): 
Synthesis of Protα (50-89) N50W was attempted several times on a PS3 synthesizer. Due to 
many unsuccessful attempts a few modifications were made to the synthesis to make a few 
couplings proceed with higher efficiency.  
The difficult steps were identified as couplings of glycine to aspartic acid, and glycine to glycine. 
In particular, the coupling of Gly59 to Gly60, Gly69 to Asp70, Gly76 to Asp77 were found to be 
challenging (underlined). To enhance the coupling efficiency at these positions, dipeptides 
Fmoc-Gly-(Dmb)Gly-OH, Fmoc-Asp(otBu)-(Dmb)Gly-OH were at their respective positions 
and residues 83 and 84 were substituted with a dimethyloxazolidine (pseduoproline) dipeptide. 
Pseudoproline helps to prevent aggregation early on in the synthesis. The dipeptide prevents 
secondary structure formation which often prevents amino acid couplings from occurring. 
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Placement of the pseudoproline earlier in the sequence (towards C-terminus) prevents the 
structure formation towards the N-terminus. Note the direction of SPPS is from C to N.                    
 
Sequence 2.1: Protα (50-89) N50W showing difficult coupling positions in green. The 
pseudoproline ES dipeptide unit is shown in purple. 
Other modifications include doubling the coupling time (double couplings), changing the 
coupling reagent to HATU instead of the standard HBTU reagent, and using a low loading resin. 
The low loading resin was expected to prevent aggregation between nearby growing peptide 
strands, thus allowing the coupling reactions to go to completion. These new strategies were 
initially used individually (for example increase the coupling times) and later on in combinations 
(for example increase coupling times and also substituted HATU instead of HBTU), in all the 
syntheses. However, we were not successful in any of our trials.  
2. Microwave Synthesis:  
Microwave synthesis is a strategy for protein synthesis which has the potential to yield very pure 
proteins. Protα(50-89)N50W was synthesized successfully on a CEM Discover microwave 
synthesizer (91). Two distinct points about microwave synthesizer are: The bulk sample was 
heated to 75 
o
C and the coupling and deprotection times were reduced to five and three minutes, 
respectively. SPPS is performed at room temperature whereas microwave synthesis is performed 
at elevated temperatures. The higher temperatures in microwave synthesizer promotes the 
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disruption of secondary structure (there is more energy to overcome intramolecular H-bonding 
interactions, etc.) and the reactions proceed faster at higher temperature. 
Purification: 
Due to the high number of hydrophilic residues in the sequence, retention on the reverse phase 
HPLC column is poor. So the peptides synthesized on the automated and microwave synthesizers 
were purified using a strong anion exchange (SAX) column. The disadvantage to the SAX 
method is that, the elution buffer contains 20 mM glycine with 1M NaCl. The samples collected 
by this method contain salt and needs to be extensively dialyzed in order to characterize it on 
ESI-MS.  Dialysis of the sample against 18 mΩ water resulted in formation of Na/TFA adducts 
that appeared as peaks spaced at 136 Da and dominate the mass spectrum (Figure 2.1) (86). 
Water was replaced by ammonium acetate and formate in dialysis to avoid the Na/TFA adducts 
formation.  
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Figure 2.1: ESI-MS of Protα sample after strong anion exchange HPLC and dialysis against 
water. Na/TFA complexes, evidenced by peaks spaced at 136 Da, dominate the signal (86). 
 
However, dialysis is highly time consuming process and results in dilution of the sample. A 
synthetic strategy using benzyl ester as a side chain protecting group was developed to avoid the 
need for SAX (92).  Protα(50-105)N50W was synthesized in a linear fashion using benzyl ester 
protected aspartic and glutamic acids. 
3. Linear synthesis using the benzyl ester (OBzl) protecting group:  
In this method, selected glutamic acid residues (E) side chain were protected with benzyl ester 
(OBzl) instead of the standard tertiary butyl (tBu) group that was used in the previous two 
methods (sequence 2.2). The OBzl group is stable to acidic conditions and will not be removed 
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when resin and other side chain protecting groups are treated with trifluoroacetic acid. Thus it 
imparts neutral charge and hydrophobicity to the carboxylic acid side chain of Glu and aids in 
the purification using reverse phase C18 column and avoids the dialysis step. The flip of charge 
from negative to neutral facilitates characterization of the synthesized peptides on positive mode 
of ESI-MS. Later, the OBzl groups can be removed quantitatively by hydrogenation. Thus the 
purification and characterization steps were made easy. Out of the 33 negative charges in the 
sequence the synthesis required netralizing only 12 glutamic and aspartic acid residues to make 
the net charge of the sequence positive.  
WEVDEEEEEGGEEEEEEEEGDGEEEDGDEDEEAESATGKRAAEDDEDDDVDTKKQK 
Sequence 2.2: Protα (50-105) N50W sequence showing the benzyl ester protected glutamic acid 
residues in green.  
The above strategy was applied in synthesizing Protα 50-105 (55mer) sequence. During the 
synthesis the coupling of Fmoc-Gly-OH to Fmoc-Glu-(OBzl)-OH was found to be problematic. 
We observed the formation of glutarimide (Figure: 2.2A and 2.2B) between these two amino 
acids. This problem was overcome by using Fmoc-Glu-(tBu)-OH for all the glutamic acids that 
precede glycine. 
The synthesis was successful until step number 59, corresponding to a 47mer. As said, the benzyl 
ester protecting group imparts hydrophobicity to the peptide thus helped in the purification using 
reverse phase column and characterization on positive ion mode. However, with increasing 
length of the target sequence when the last 8 amino acids were added, the sequence could not be 
characterized on the positive ion mode because of excessive charge neutralization of the peptide 
by the benzyl ester group.   
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Figure 2.2: A. Growing peptide chain showing no glutarimide formation B. Glutarimide 
formation between glycine and glutamic acid in a growing peptide chain. Note, glutaramide 
formation can be detected by a characteristic change is mass. 
The limitations of the strategies used to synthesize Prot(50-89)N50W and Prot(50-105)N50W 
highlight the need for a protecting group that can aid in the purification and characterization of 
longer negatively charged sequences by positive ion mode MS.  
 
 
 
 
Weight of cyclized Glu(OBzl)-111.59 Da Weight of Glu(OBzl)- 219.59 Da 
A B 
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Section 2.2 Research Strategy 
Like mentioned earlier, synthesis, purification, and characterization of highly acidic sequences 
has been challenging (86, 93). Though the methods described in section 2.1 were successful in 
synthesizing the acidic Protα(50-89)N50W segment it would be more advantageous to avoid 
SAX for purification. To this end the benzyl ester protecting group was employed in the 
synthesis. However, this group also has its own disadvantage that was described in section 2.1.  
Our goal was to develop a protecting group strategy that would allow purification by reverse-
phase HPLC and characterization by ESI-MS in positive-ion mode. The 4-pyridylmethyl ester 
(abbreviated as OMePyr), also referred to as the 4-picolyl ester, introduced by Young possesses 
the necessary characteristics to make this possible; it is weakly basic yet non-nucleophilic and 
compatible with all the reaction conditions encountered in standard Fmoc- and t-Boc-based 
solid-phase peptide syntheses (94, 95, 96). It was originally designed as a ‘handle’ that allowed 
for the solution-phase synthesis of peptides; placement at the C-terminus of a growing peptide 
chain enabled the peptide to be captured by an ion-exchange resin as excess reagents from a 
coupling or deprotection step were removed. The impetus for the development of the 4-
pyridylmethyl ester stemmed from concerns about the inherent steric hindrance of the solid-
phase methodology being pioneered by Merrifield. As convergent peptide synthesis became 
viewed as the prime strategy for synthesizing large peptides or proteins the generally low 
solubility of protected peptide segments was noted as a problem. The 4-pyridylmethyl ester 
protecting group was shown to increase the solubility of protected peptide segments allowing for 
purification by reverse-phase HPLC (97, 98) .  
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Comparison of 4-pyridylmethyl ester with benzyl ester 
Esters of both these molecules are acid resistant and will not be removed when resin and other 
side chain protecting groups are cleaved from the peptide. So using  any of these two groups as a 
side chain protecting group on negatively charged amino acids would keep those amino acids 
protected when the rest of the side chain protecting groups, and resin are cleaved from the 
peptide using strong acid like trifluoroacetic acid. In this way, we keep the negative charges on 
those amino acids masked and the groups impart hydrophobicity facilitating the purification of 
negatively charged sequences on reverse phase C18 column, and characterization on the positive 
ion mode of ESI-MS. Further, the groups can be removed by hydrogenation in the presence of 
palladium catalyst. 
           
Figure 2.3: Structures of benzyl alcohol and 4-pyridinemethanol 
 
Selection of the 4-pyridylmethyl ester moiety over benzyl ester as a protecting group stemmed 
from the basic yet non-nulceophilic nature of the pyridine ring. The pKa of the 4-pyridylmethyl 
ester in its acidic form should be close to that of pyridine, which is 5.25. This ensures that a 
significant proportion of 4-pyridylmethyl ester protected side-chains will be protonated under the 
conditions typically employed in RP HPLC and ESI-MS thus, the group flips the negative charge 
on carboxylic acids of aspartic and glutamic acid to a positive charge making the characterization 
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of negatively charged sequences possible on positive ion mode of ESI-MS.  Whereas the benzyl 
ester group cannot be protonated and flips the charge from negative to neutral thus making 
characterization of large peptides challenging using positive mode of ESI-MS.  
4-pyridinemethanol protected glutamic acid and aspartic acid are not commercially available. 
Different synthetic strategies were explored for the synthesis of 4-pyridylmethyl ester side chain 
protected glutamic and aspartic acid. N-terminally Fmoc protected and C-terminally tertiary 
butyl group (tBu) protected glutamic and aspartic acids were used as starting materials. The side 
chain carboxyl group was not protected and readily reacts with the incoming alcohol. After 
synthesis the 4-pyridylesters were purified and characterized. 
Later on a model peptide for testing the use of 4-pyridinemethanol-protected amino acids were 
used. We chose a model peptide that is easy to synthesize (sequence 2.3) 
A) WGAELAG       B)  WGADLAG 
Sequence 2.3: Model peptides showing the position of 4-pyridylmethyl-protected glutamic acid 
and aspartic acid in green 
The highlighted residue E in the sequence marks the site of the proposed 4-pyridinemethanol- 
protected glutamic acid. As already said, the protecting group is acid resistant, so we expect it to 
remain intact when the resin and other side chain protecting groups are cleaved using strong acid. 
The purification can be carried out on a reverse phase column and characterization on positive 
ion mode of MS.  
After purification and characterization of the peptide model was complete the 4-
pyridinemethanol protecting group was removed by hydrogenation in the presence of palladium 
catalyst as shown in the scheme 2.1.  
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Scheme 2.1: Hydrogenation of 4-pyridinemethanol protected glutamic acid. 
If the small peptide is successfully prepared, the new side chain-protected amino acid can then be 
applied in the synthesis of Protα peptide derivatives. 
                        WEVDEEEEEGGEEEEEEEEGDGEEEDGDEDEEAESATGKR  
Sequence 2.4: Protα(50-89)N50W showing negatively charged residues in red and positively 
charged residues in green.  
             
There are a total of 25 negatively charged and 2 positively charged residues in the sequence of 
Protα50-89N50W (sequence 2.4). By installing 4-pyridinemethanol aspartic or glutamic acid 
only in 5 positions in the sequence and continuing to use benzyl ester protected aspartic and 
glutamic acid in rest of the positions the overall charge on the peptide can be made positive. This 
minimizes the number of 4-pyridylmethyl esters of aspartic and glutamic acid required in the 
synthesis. 
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2.3 Synthesis, purification, and characterization of 4-pyridylmethyl ester of 
aspartic and glutamic acid. 
 
Compound 3 was synthesized by straightforward esterification through in situ activation of 1 
using HBTU and reaction with 4-pyridinemethanol followed by removal of the t-butyl protecting 
group (Scheme 2.2). 
 
 
Scheme 2.2: Synthesis of Nα-Fmoc-L-glutamic acid γ-4-pyridylmethyl ester (3a) and Nα-Fmoc-
L-aspartic acid γ-4-pyridylmethyl ester (3b) (163). 
 
The starting material, intermediates, and final products were dissolved in acetone-d6 to obtain 
1
H 
NMR spectra. ESI-MS was also obtained using 1:1 ratio of acetonitrile and water as solvent.  
 Synthesis of Nα-Fmoc-L-glutamic acid α-t.-butyl ester -4-pyridylmethyl ester (2a) 
Compound 2 was synthesized by treating 0.71 mmol of N α-Fmoc-L-glutamic acid α-t.-butyl 
ester (1) with 0.71 mmol of HBTU, 0.71 mmol HOBt, 1.4 mmol 4-pyridinemethanol, and 2.85 
mmol DIEA in 10 mL of DMF for 6 hr at room temperature. The solvent was removed under 
reduced pressure and the reaction mixture was dissolved in dichloromethane, washed with water, 
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dried over Na2SO4, filtered, and evaporated to give compound 2. A light yellow solid product 
was obtained in 70.4% yield. 
Characterization:  
1
H NMR (acetone-d6) δ 8.69 (broad d, 2H), 7.87 (d, 2H), 7.81 (d, 2H), 7.70 (broad d, 2H), 7.44 
(t, 2H), 7.35 (t, 2H), 6.07 (broad s, 1H), 5.33 (d, 2H), 4.36 (m, 2H), 4.25 (t, 1H), 4.13 (m, 1H), 
2.57 (t, 2H), 2.30 (m, 2H), 1.45 (s, 9H). 
 ESI MS: m/z for C30H32N2O6 calc. 516.2260, [M+H]
+
 found 517.2376. 
 
Figure 2.4: ESI-MS spectrum of Nα-Fmoc-L-glutamic acid α-t.-butyl ester -4-pyridylmethyl 
ester (2a) showing [M+H]
+
 and [2M+H]
+
. 
 
Nα-Fmoc-L-glutamic acid -4-pyridylmethyl ester (3a) 
A 0.42 mmol quantity of compound 2 was dissolved in 1 mL of TFA/H2O/TIS (95/2.5/2.5) and 
stirred for 3 hr. The product was precipitated with cold diethyl ether, centrifuged to collect a 
solid yellow product in 69.2% overall yield (i.e. calculated starting from compound 1). 
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Characterization:  
1
H NMR (acetone-d6) δ 8.69 (broad d, 2H), 7.87 (d, 2H), 7.81 (d, 2H), 7.70 (broad d, 2H), 7.44 
(t, 2H), 7.35 (t, 2H), 6.07 (broad s, 1H), 5.33 (d, 2H), 4.36 (m, 2H), 4.25 (t, 1H), 4.13 (m, 1H), 
2.57 (t, 2H), 2.30 (m, 2H).  
ESI MS: m/z for C26H24N2O6  
 calc. 
460.1634, [M+H]
+
 found 461.1066. 
Figure 2.5: ESI-MS spectrum of Nα-Fmoc-L-glutamic acid -4-pyridylmethyl ester (3a) 
showing [M+H]
+
 and [2M+H]
+
. 
 
Nα-Fmoc-L-aspartic acid α-t-butyl ester α-4-pyridylmethyl ester (2b) 
A 1.26 mmol quantity of Nα-Fmoc-L-aspartic acid α-t-butyl ester (1b) was treated with 1.26 
mmol of HBTU, 1.26 mmol HOBt, 2.52 mmol 4-pyridinemethanol, and 5.04 mmol DIEA in 10 
mL of DMF for 6 h at room temperature. The solvent was removed under reduced pressure and 
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the reaction mixture was dissolved in dichloromethane, washed with water, dried over Na2SO4, 
filtered, and evaporated to give compound 2b. A light yellow solid product was obtained in 
72.4% yield. 
Characterization: 
1
H NMR (acetone-d6) δ 8.66 (broad d, 2H), 7.85 (d, 2H), 7.78 (d, 2H), 7.69 (broad d, 2H), 7.49 
(t, 2H), 7.35 (t, 2H), 6.07 (broad s, 1H), 5.31 (d, 2H), 5.07 (t, 1H), 4.34 (m, 2H), 4.13 (m, 1H), 
2.87 (m, 1H), 2.50 (m, 1H), 1.45 (s, 9H).  
 ESI MS: m/z for C29H30N2O6 calc. 502.2104, [M+H]
+ 
found 503.2776. 
 
Figure 2.6: ESI-MS spectrum of Nα-Fmoc-L-aspartic acid α-t-butyl ester α-4-pyridylmethyl 
ester (2b) showing [M+H]
+
.
 
 
Nα-Fmoc-L-aspartic acid α-4-pyridylmethyl ester (3b) 
A 0.42 mmol quantity of Nα-Fmoc-L-aspartic acid α-t-butyl ester α-4-pyridylmethyl ester (2b) 
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was dissolved in 1 mL of TFA/H2O/TIS (95/2.5/2.5) and stirred for 3 h. The product was 
precipitated with cold diethyl ether, centrifuged to collect a solid yellow product in 70.3% 
overall yield. 
Characterization: 
1
H NMR (acetone-d6) δ 8.66 (broad d, 2H), 7.85 (d, 2H), 7.78 (d, 2H), 7.69 (broad d, 2H), 7.49 
(t, 2H), 7.35 (t, 2H), 6.07 (broad s, 1H), 5.31 (d, 2H), 5.07 (t, 1H), 4.35 (m, 2H), 4.13 (m, 1H), 
2.87 (m, 1H), 2.50 (m, 1H).   
ESI MS: m/z for C25H22N2O6 calc. 446.1478, [M+H]
+ 
found 447.2066. 
 
 
 Figure 2.7: ESI-MS spectrum of Nα-Fmoc-L-aspartic acid α-4-pyridylmethyl ester (2b) 
showing [M+H]
+
.
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2.4 Application of 4-pyridylemethyl esters of aspartic and glutamic acid in the 
synthesis of model peptides 
The ultimate goal of developing a protecting group is to be able to use it in peptide synthesis. 
The 4-pyridylmethyl ester protected glutamic acid (3a) and aspartic acid derivatives (3b) readily 
couple with free amines under the typical conditions employed for solid-phase peptide synthesis 
and were used in the synthesis of the heptapeptides Ac-WGAELAG-NH2 (5a) and Ac-
WGADLAG-NH2 (5b) respectively. A hexapeptide Ac-WGAELAG-NH2 with standard tBu 
protected glutamic acid was also synthesized (Scheme 2.3). 
Peptide Synthesis 
Peptides were synthesized using a Protein Technologies Inc. PS3 peptide synthesizer. All the 
peptides were synthesized on the 0.1 mmol scale using rink amide MBHA resin with 0.3 mmol/g 
substitution. Upon cleavage, the peptide produced from this resin was C-terminally amidated. 
Coupling of each amino acid was carried out in DMF using 4 equiv. Fmoc-amino 
acid/HBTU/HOBt and 4 equiv. DIEA with a 1 h coupling time.  When compound 3 was 
incorporated into a peptide, 2 equiv. of Fmoc-amino acid/HBTU/HOBt were used. The Fmoc 
group was removed using 20% v/v piperidine in DMF with a reaction time of 30 min. The final 
peptide was acetylated using 2 mL of acetic anhydride and 4 eq. DIEA in DMF. After synthesis 
the resin was washed with dichloromethane, methanol and then dried. The dried resin was treated 
with a TFA/TIS/H2O (95/2.5/2.5) solution for 2 h. The reaction mixture was filtered and the 
peptide precipitated with cold diethyl ether. The precipitate was collected, dissolved in water and 
freeze dried. The peptide was purified and characterized by HPLC and ESI-MS respectively and 
mass of the dried peptide was obtained to calculate percentage yields. 
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Purification by HPLC 
Crude peptides were purified on a RP column using 0.1% TFA in water (Buffer A) and 0.1% 
TFA in acetonitrile (Buffer B).  After injection, isocratic elution at 100% Buffer A was run for 3 
min. followed by gradient elution from 100% Buffer A to 0% Buffer A in 37 min. with a flow 
rate of 1.0 mL/min.  Peptide signals were detected at both 214 nm and 280 nm. 
Characterization 
All peptides were characterized by ESI-MS after elution from HPLC, and thus were dissolved in 
water/acetonitrile containing 0.1% TFA.  Sample was delivered to the ESI source with a KD 
Scientific syringe pump at 10 μl/min, and the electric potential used to initiate ESI (i.e. capillary 
voltage) was 2500 V.  The source temperature was set at 90 °C and the desolvation temperature 
at 275 
o
C with a cone gas flow of 10 L/hr and a desolvation gas flow of 500 L/hr. 
ESI-MS: m/z for peptide 4a calc. 834.3680, [M+H]+ found 835.3341; peptide 4b calc. 820.4345, 
[M+H]+ found 821.4673; peptide 5a calc. 743.4531, [M-H]
-
 found 742.4236; peptide 5b calc. 
729.3367, [M-H]
-
 found 728.3865. 
Hydrogenation 
 
As said in section 2.2 the 4-pyridylmethyl group was removed by overnight hydrogenation. The 
peptide was dissolved in 10 mL of ethyl acetate and 2 mg of 5% Pd/C was added.  The reaction 
flask was placed under a hydrogen atmosphere of 70 psi and shaken overnight using a Parr 
hydrogenator.  The Pd/C catalyst was removed by filtration through a fritted glass filter and the 
ethyl acetate was removed under reduced pressure. 
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Scheme 2.3: Synthesis of Ac-WGAELAG-NH2 (5a) and Ac-WGADLAG-NH2 (5b) using 4-
pyridylmethyl ester side chain protection for glutamic acid and aspartic acid (method 1) and 
using t-butyl ester side-chain protection for gluatmic acid (method 2). The 4-pyridylmethyl ester 
group is abbreviated as –OMePyr and the circle represents the solid phase support (163). 
 
Percent Yields 
The coupling efficiency of 3a appears comparable with other standard side chain-protected Glu 
amino acids as peptide 4a was obtained in 89.2% yield. The 4-pyridylmethyl ester was removed 
in near quantitative yield by hydrogenation using 5% Pd/C in ethyl acetate, thus exposing the 
carboxyl side chain of Glu (95.7% yield). Addition of the extra hydrogenation step decreases the 
overall yield of peptide 5a slightly (86.6% yield, Scheme 2, method 1) when compared with 
synthesis employing a standard t-butyl ester-protected Glu (88.9% yield, Scheme 2, method 2). 
An analogous heptapeptide Ac-WGADLAG-NH2 (5b) was synthesized containing a 4-
pyrdinemethyl ester-protected aspartic acid residue (Scheme 2, method 1). The peptide 5b was 
obtained in 90.2% overall yield. 
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Discussion:  
The peptides Ac-WGAE(OMePyr)LAG-NH2 (4a) and Ac-WGAD(OMePyr)LAG-NH2 (4b) were 
readily detected by positive mode ESI-MS as a singly charged species (Figure 2.8A).  However, 
the peptides Ac-WGAELAG-NH2 (5a) and Ac-WGADLAG-NH2 (5b), which lack the 4-
pyridylmethyl ester protecting group, were not observed by positive mode ESI-MS using 
common conditions and operating parameters (data not shown).  This result is not surprising as 
they lack even weakly basic sites and are predicted to have an overall charge of zero in the 0-3 
pH range.  Peptides 5a and 5b were detected by negative ion mode ESI-MS as a singly charged 
species thus allowing for characterization in this case (Figure 2.8B). 
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Figure 2.8: A) Positive ion-mode ESI-MS of peptide 4a containing 4-pyridylmethyl ester 
protected glutamic acid. B) Negative ion-mode ESI-MS of peptide 5a. Note, peptide 5a was not 
observed by positive ion-mode ESI-MS using standard conditions and operating parameters 
(163). 
 
The work demonstrates the effectiveness of the 4-pyridylmethyl ester protecting group 
(abbreviated OMePyr) in switching the charge state of a peptide from negative to positive, thus 
making detection by positive ion mode ESI-MS possible. 
Although peptides 5a and 5b, which lack any basic groups, were detected by negative ion mode, 
ESI-MS problems have been noted in the analysis of highly acidic sequences.  In particular, the 
high net negative charge of these peptides causes them to attract and retain adventitious sodium 
ions.  This leads to reduced sensitivity of the mass spectral analysis because the ion intensity is 
spread across a wide distribution of peptide–sodium complexes.  As strong anion exchange 
A 
B 
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(SAX) is often the method of choice for purification of such sequences, sodium or other salts are 
necessarily introduced to the sample.  Further, ion-pairing agents like TFA, which is widely used 
in peptide synthesis and purification, also interfere in negative mode ESI-MS as pre-ionized 
sodium/TFA adducts appear with very high intensities.  In many cases, these ion pairs 
completely mask the presence of analyte in mass spectra. 
Use of 4-pyridylmethyl ester side-chain protection in conjunction with the benzyl ester side-
chain protection increases the hydrophobicity of otherwise hydrophilic peptides so that 
purification by RP HPLC is possible.  Table 1 shows the retention times of three hexapeptides 
composed solely of glutamic acid synthesized using different protecting group strategies.  Use of 
exclusively t-butyl ester protecting groups, which are removed during cleavage from the resin, 
yields a peptide with 11.2 min retention time using a standard gradient. Inclusion of three benzyl 
ester groups lengthens the retention time to 22.2 min whereas use of two benzyl esters in 
addition to one 4-pyridylmethyl ester gives a retention time of 19.3 min.  Thus, the 
chromatographic properties of the peptide can be controlled with the judicious use of a 
combination of these two protecting groups. 
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Table 2.1: HPLC retention times for hexapeptides composed of glutamic acid synthesized using 
different protecting group strategies. HPLC run conditions: Buffer A: 0.1% TFA (Trifluoroacetic 
acid) in acetonitrile, Buffer B: 0.1% TFA in water. Isocratic elution with 100% B for 2 min, 
gradient elution with 100% B to 0% B for 32 min, and Isocratic with 100% A for 5 min (163).  
 
Due to the “charge flipping” afforded by the 4-pyridylmethyl group, eluted peptides can be 
readily characterized using positive mode ESI-MS.  After drying, hydrogenation yields the final 
peptide product without introduction of salts or excess TFA so characterization can be performed 
using negative mode ESI-MS. 
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Section 2.5 Conclusions 
Problems associated with characterization can easily lead one to the conclusion that a synthesis 
has failed when in fact it has not. It is critical to develop a purification method that is compatible 
with ESI-MS. The method presented herein can be easily and quickly applied to the 
characterization of a variety of highly acidic peptides. 
The 4-pyridylmethyl ester serves as a useful protecting group for glutamic acid and aspartic acid 
in solid-phase peptide synthesis and allows for the charge state of a peptide to be switched from 
negative or neutral to positive, thus allowing for characterization by positive mode ESI-MS. In 
conjunction with benzyl esters, the 4-pyridylmethyl ester allows for the chromatographic 
properties to be modified such that peptides that otherwise have very short retention times or no 
retention at all on a standard RP HPLC column can be retained. The OMePyr group is readily 
removed from peptides in high yield by hydrogenation. For larger sequences, combining the 4-
pyridylmethyl ester protecting group with benzyl ester protection reduces the number of the 
former needed to produce a net positive charge and allows for purification by RP HPLC. 
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Chapter 3 
Zn2+-induced structural changes in Protα(50-89)N50W studied using CD 
spectroscopy 
Section 3.1 Introduction to Circular Dichroism Spectroscopy 
 
Circular dichroism (CD) is the difference in the absorption of left‐handed circularly polarized 
light (L‐CPL) and right‐handed circularly polarised light (R‐CPL) and occurs when a molecule 
contains one or more chiral chromophores (light‐absorbing groups): 
Circular dichroism = ΔA (λ) = A (λ)LCPL ‐ A(λ)RCPL  
where λ is the wavelength and A is the absorbance. 
For CD measurements the most important features required for a sample are presence of chirality 
and chromophore group. The technique is extensively used to study chiral molecules of all types 
and sizes. CD can be used to study structural aspects of chiral molecules and their interactions 
with other molecules. 
CD Instrumentation 
Most commercial CD instruments are based on the modulation techniques introduced by 
Grosjean and Legrand. Light is linearly polarized and passed through a monochromator. The 
single wavelength light is then passed through a modulating device, usually a photoelastic 
modulator (PEM), which transforms the linear light to circular polarized light. The incident light 
on the sample switches between LCP and RCP light. As the incident light switches direction of 
polarization, the absorption changes and the difference in molar absorptivity can be calculated 
(Figure 3.1).                                                                      
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Figure 3.1: The instrumentation for a common CD spectrometer showing the polarization of 
light and the differential absorption of LCP and RCP light. 
 
 A primary use of CD is in analyzing the secondary structure or conformation of 
macromolecules, particularly proteins. As secondary structure is sensitive to its environment, 
temperature or pH, circular dichroism can be used to observe how secondary structure changes 
with environmental conditions or on interaction with other molecules. Structural, kinetic and 
thermodynamic information about macromolecules can be derived from circular dichroism 
spectroscopy. 
The most widely studied circular dichroism signatures are the various secondary structural 
elements of proteins such as the α‐helix, the β sheet, and the random coil.  
Strengths and weakness of CD 
The advantages of CD are derived from speed and convenience of the technique. Compared with 
the X-ray crystallography and NMR, CD can obtain a good quality of spectra both in near and far 
UV CD studies within 30 min time. Far UV CD studies, in particular, require only small amounts 
of material and since the technique is non-destructive, it is usually possible to recover most or all 
of the solution and hence one can conduct multiple experiments on the same sample. The ability 
to use cells of path lengths differing by several orders of magnitude means that it is relatively 
easy to study a very wide range of protein concentrations. This latter point represents an 
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important advantage of CD over Fourier Transform Infra Red (FTIR) spectroscopy which can 
give useful information about the secondary structure of proteins, but under a more restricted 
range of experimental conditions (99). In addition, CD studies can be performed over a wide 
range of experimental conditions, including pH and temperature (with suitable attention to the 
requirement to avoid excess absorption or scattering of the incident radiation). Developments in 
instrumental design have now also made it possible to use stopped flow CD to study structural 
changes in proteins which occur on the timescale of a few tens of milliseconds (100, 101). 
CD of Proteins: 
The most common use of CD in proteins is to compare global structural features of two 
macromolecules, or to analyze a single molecule under different conditions. This can be used 
simply to ascertain if a newly purified protein is correctly folded, determine if a mutant protein 
has folded correctly in comparison to the wild‐type, or for the analysis of biopharmaceutical 
products to confirm that they are still in a correctly folded active conformation. 
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Figure 3.2: CD spectrometer showing the wavelengths and structural types it can identify in 
proteins. 
 
Chromophores commonly observed in CD studies of proteins 
CD can measure various aspects of protein structure.  There are two types of optically active 
chromophores in proteins. In far UV CD the peptide bond is the principal absorbing group. 
Studies in this region can give information about the secondary structure. In near UV CD 
aromatic side chains of amino acids such tryptophan, tyrosine, and phenylalanine absorb in 250-
290 nm range (Figure 3.2). 
In addition, non-protein components or cofactors, such as pyridoxal-5'-phosphate, haem, flavin, 
bacteriochlorophyll, or added ligands may absorb in regions of the spectrum well separated from 
those of amino acids and peptide bonds. The CD signals in these regions can be used to provide 
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detailed information on the environment and possible interactions between these cofactors or 
ligands. 
The contribution of the peptide bond and aromatic amino acid side chains in identifying the 
secondary structure of the protein will be discussed in detail. 
The peptide bond 
In the far UV region (typically 240 nm to 190 or 180 nm) the absorbing group is principally the 
peptide bond. There is a weak but broad       transition centered around 210 nm and an 
intense       transition at about 190 nm (102). Studies of far UV CD can be used to assess 
quantitatively the overall secondary structure content of the protein (Figure 3.3).  
Aromatic side chains 
Based on the location of the side chains and type of amino acid containing side chain the 
secondary structure of a protein gives characteristic near UV CD spectrum. Each of the aromatic 
amino acids tends to possess a characteristic wavelength profile (103). Tryptophan, a peak close 
to 290 nm with fine structure between 290 and 305 nm; tyrosine, a peak between 275 and 282 
nm (the fine structure at longer wavelengths may be obscured by that from tryptophan); 
phenylalanine, sharp fine structure between 255 and 270 nm. 
The types of information that can be obtained from CD of proteins and peptides include 
secondary structure content, conformational changes, and protein and peptide refolding. 
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Figure 3.3: Far UV CD spectra of different secondary structures in proteins. The Figure shows 
the CD spectrum of α-helix, β-sheet, and random coil.  
 
CD studies of intrinsically disordered proteins 
Extended IDP’s are disordered under physiological conditions because of the strong electrostatic 
repulsion and weak hydrophobic interactions. IDP’s with their highly biased amino acid 
sequences might possess unusual conformational responses to changes in environments such as 
strong denaturants, temperature, pH, counter ions, osmolytes, binding partners, and molecular 
crowding (104)  
Effect of Temperature 
The analysis of the temperature effects on structural properties of several extended IDP’s 
revealed that native coils and native pre-molten globules possess a so-called “turned out” 
response to heat.  This is illustrated in Figure 3.4 where the temperature induced changes in the 
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far-UV CD spectrum of human α-synuclein is shown (105, 106). The temperature dependence of 
the CD signal at 222 nm ([θ]222 characteristic wavelength of α-helix) for several extended IDPs 
(Figure 3.4, 3.5, 3.6) is shown. Figure 3.4 shows that at low temperature α-synuclein possessed a 
far-UV CD spectrum typical of an unfolded peptide chain. As the temperature was increased, the 
shape of the spectrum changed, reflecting the temperature induced formation of secondary 
structure. The spectrum also shows the presence of an isodichroic point (isosbestic point) at 
about 208 nm – that is a wavelength at which the total absorbance of the sample does not change 
during the heating process (or chemical process in the case of pH or binding, etc.). This indicates 
a two state process – presumably an unfolded state going to a more folded or collapsed state. 
This temperature inducing formation of α-helix is better illustrated by plotting [θ]222 versus 
temperature for α-synuclein (Figure 3.4 inset) (105-107), caldesmon 636-771 fragment (119) 
(Figure 3.5), and phosphodiesterase γ-subunit (Figure 3.6) (108) (109). The major structural 
changes observed over the range of 20 to 90 
o
C and further heating beyond 90 
o
C was 
accompanied by less pronounced effects. The structural heat induced changes in all these IDP’s 
were completely reversible. Thus, an increase in temperature induces partial folding of IDP’s, 
rather than the unfolding typical of ordered globular proteins, which was referred to as “turned 
out” response to heat.  
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Figure 3.4: The temperature-induced changes in the far-UV CD spectrum of human α-synuclein. 
Far-UV CD spectra were measured at increasing temperatures: 3.0, 9.0, 19.0, 31.0, 39.0, 45.0, 
53.0, 62.0, 72.0, 82.0, and 92.0 
o
C. The molar ellipticity of the peak at approximately 198 nm 
becomes more negative and shifts to lower wavelengths with increasing temperature (105). 
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Figure 3.5: Effect of temperature on far UV CD spectra of chicken gizzard wild type caldesmon 
(636-771 fragment) and its mutants, depicted as [θ]222 vs. temperature (110). 
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Figure 3.6: The temperature-dependence of [θ]222 of γ-subunit of phosphodiesterase (108, 109). 
 
Effect of pH 
Extended IDP’s are also characterized by the “turned out” response to changes in pH. Figure 3.8 
represents the pH dependence of α-synuclein (105, 106) and prothymosin-α as monitored by CD 
(59). It is clearly seen that there was a little or no change in the far UV CD spectra between pH 
9.0 and 5.5. However, a decrease in pH from 5.5 to 3.0 resulted in a substantial increase in 
negative ellipticity at 220 nm. It has been established that the pH induced changes in far UV CD 
spectra of these two proteins were completely reversible and consistent with the formation of 
partially folded pre-molten globule like conformation. Similar pH-induced structural 
transformations have been described for such extended IDPs as pig calpastatin domain I (111), 
histidine rich protein II (112), and naturally occurring human peptide LL-37 (113). These 
observations show that a decrease in pH induces partial folding of extended IDPs due to 
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minimization of their large net charge present at neutral pH, thereby decreasing charge/charge 
intramolecular repulsion and permitting hydrophobic-driven collapse to the partially folded 
conformation. In contrast to this, for a folded protein a pH drop to acidic range (pH 1-3) would 
result in protein denaturation and loss of tertiary structure. The net charge on the protein due to 
the titration of all the ionizing groups leads to intramolecular charge-charge repulsion, which is 
sufficient to overcome the attractive forces (mostly hydrophobic and dispersive) resulting in at 
least partial unfolding of the protein.   
 
Figure 3.7: The effect of pH on structural properties of IDPs. The pH dependence of [θ]222 for α-
synuclein and Protα (30, 59, 105). 
 
Effect of counter ions 
Interactions of IDPs with ligands that affect their net charge and net hydrophobicity often allow 
the protein to adopt more regular structure approximating the structure seen in more ordered 
proteins. This hypothesis is illustrated by seven IDPs in the presence and absence of cationic 
species. In Figure 3.9 the black circles correspond to the ligand-free proteins whereas open 
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circles represent proteins complexed with particular metal cations. The solid line represents the 
border between IDPs and folded proteins (16, 43). By this analysis metal binding can induce 
structure and this idea is well supported by Figure 3.10. Several cations (monovalent, divalent, 
and trivalent) were shown to induce conformational changes in α-synuclein and transformed this 
extended IDP into partially folded conformation. The folding strength of cations increases with 
increase in ionic charge density. Human anti-bacterial protein LL-37, a natively unfolded protein 
with a high net positive charge was shown to be folded in the presence of several anions (113).  
 
 
Figure 3.8: The effect of counter ions on the ratio of mean net charge to mean hydrophobicity of 
IDPs. Charge-hydropathy plot for seven extended IDPs, ostecalcin, osteonectin, α-casein, 
HPV16E7 protein, calsequestrin, manganese stabilizing protein and HIV-1 integrase in their apo-
form (black circles) and metal-saturated (white circles) forms (16). Ca2+, Mn2+, and Zn2+ are the 
cations used in the study. 
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Figure 3.9: The far-UV CD spectra of α-synuclein in the presence of various metal cations (105). 
 
Elucidation of the molecular features and biophysical properties of IDPs with environmental 
changes will provide more insight into their function and potentially novel mechanisms of action, 
thus contributing to a more complete understanding of IDP’s metal binding. It will be interesting 
to see if IDPs as a whole make use of fundamentally different metal binding motifs than their 
structured counter parts. Information on even a few proteins of this class will give insight into 
whether a lack of structure is a way to confer multi-functionality to a single protein. 
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Section 3.2 Research Strategy 
Protα(50-89)N50W is used as a model peptide to carry out CD studies. Though 48-110 region of 
the protein is found to be the metal binding region, like mentioned in section 1.5 most of the Zn
2+
 
binding ligands (long stretches of Glu and Asp) are located most likely in the central 50-89 
region of the protein. In general, the most common ligands for Zn
2+
 are cysteine and histidine. 
However, Protα completely lacks any of these residues. The next possible ligands are 
carboxylate groups in the side chains of glutamic and aspartic acid (114, 115).  
So the 50-89 segment of Protα was chosen as a model peptide for the CD studies.  Below is the 
sequence of Protα(48-100) and Protα(50-89). 
A.)  A D N E V D E E E E E G G E E E E E E E E G D G E E E D G D E D E E A E S A T 
G K R A A E D D E D D D V D T K K Q K T D E D D 
B.) N E V D E E E E E G G E E E E E E E E G D G E E E D G D E D E E A E S A T G K R 
 
Sequence 3.1: Sequence of Prothymosin showing A. 48-100 segment with 50-89 region 
highlighted. B. The central acidic region from residues 50-89. 
 
Specific Aim 1.2 Determine the structural changes in the central segment of Protα in the 
presence of environmental factors like Zn
2+
 and temperature 
The Zn
2+
 study using Protα(50-89)N50W will provide insight into the amount of structural 
change that occurs in this region versus in the full peptide. IDPs are known to gain structure at 
increased temperatures (116) and it will be interesting to see if this is the case with Protα. This 
study would show if the character of the structure adopted by the peptide is similar to that of the 
full length Protα when it binds Zn2+.  
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1.2 A. Zn2+ induced structural changes in Prothymosin-α (50-89 N50W) observed by CD 
Spectroscopy  
We hypothesize that the structural changes in the protein occur primarily in the central region. 
Our first aim was to look for the structural changes in the central segment of the protein in the 
presence of Zn
2+
 by using CD. The central 50-89 segment was used to carry out these studies. 
CD measurements were made by titrating zinc into the peptide solution. Spectra obtained from 
these experiments were compared to the CD spectrum of the full length protein (43)  
In this direction, our initial step was to determine the optimum concentration of the peptide that 
would give us a good signal on CD. The peptide at the determined concentration was then 
titrated with varying amounts of zinc. CD spectra were obtained for each addition of zinc. The 
data obtained was overlaid to look for the structural changes in the peptide at different 
concentrations.  
Experiments:  
All CD measurements were carried out on a Jasco J-815 CD Spectrometer using a 0.1 mm 
cylindrical quartz cell, 250 nm to 190 nm wavelength at 25 
o
C. The peptide and zinc chloride 
solutions were prepared in a 50 mM phosphate buffer and adjusted the pH to 7.4.  
Expected results:  
The peptide and the full Protα are highly negatively charged and have strong electrostatic 
repulsion resulting in mostly unfolded structure to the protein. Cationic metal ions like Zn
2+
 are 
expected to establish electrostatic interactions with acidic side chains resulting in reduction of 
repulsion and thereby causing folding of the peptide. Since the full protein has been shown to 
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adopt a more ordered structure upon addition of Zn, we expect zinc to induce same transition in 
the peptide also. 
1.2 B. Temperature-dependent structural changes in Prothymosin-α(50-89)N50W 
A large number of CD studies have demonstrated that a structural change takes place in IDPs 
with increasing temperature which most likely reflects formation of transient α-helices (116). The 
studies show that the temperature-induced structural change is common among IDPs and is 
accompanied by a contraction of the conformational ensemble. Structural changes in Protα as a 
function of pH and Zn
2+
 have been studied before. However temperature dependent CD studies 
of Protα have not been reported. 
Experiments 
Initially optimum concentration of Protα(50-89)N50W that gives us good signal was  determined 
to be 0.0168 mM. A cell with 1 mm pathlength was used. The peptide was then heated from 20-
80 
o
C. Once the peptide reached 80 
o
C it was cooled down to 20 
o
C. The heating and cooling 
processes were carried out by a 10 
o
C increase and decrease respectively for each run. The 
system was equilibrated for 15 min for every 10 
o
C raise in temperature.  
In the second set of runs the peptide with 50 eq of Zn
2+
 added to it was heated and cooled again. 
IDPs are shown to attain secondary structure at high temperatures. Since that was true in the case 
of Protα(50-89)N50W, structural changes of Protα(50-89)N50W under the influence of two 
factors; Zn
2+
 and heat were observed. These experiments help us understand the effect of 
temperature in the presence of metal cations.  
1.2 C. Zn
2+
 induced structural changes in polyglutamic acid sequence 
Polyglutamic acid (polyE) sequences are known to bind Zn
2+
 (43). The effects of Zn2+ on the 
structural features of a polyglutamic acid containing the same number of residues as Protα(50-
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89)N50W were studied using far UV CD. This helps us answer if the structural changes in Protα 
and its peptides occur solely due to electrostatic interactions with Zn
2+
 or if there is sequence 
specificity that causes the structural change. 
 
Ac-WEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEKR-NH2 
 
Sequence 3.2: Polyglutamic acid sequence having same number of residues as Protα(50-
89)N50W.  
 
A polyE sequences (shown above sequence 3.2) has been synthesized. Two spectra of polyE one 
with 200 eq of Zn
2+
 and the other without Zn
2+
 were obtained. 
Expected Results:  
We expect to see no change in the secondary structure of polyE in the presence of Zn
2+
 because 
of sequence specificity of Zn
2+
 to Protα which is not present in PolyE. 
Aggregation 
Aggregation or self-association is a characteristic property of intrinsically disordered proteins. 
As Protα belongs to the class of “natively unfolded” proteins, increase in temperature may 
accompany self-aggregation. To test this data obtained at same temperature in the heating and 
cooling cycle will be overlaid. If there is no self-aggregation in the sample both spectra overlay 
upon each other.  
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Section 3.3 CD Measurements 
Metal and temperature-induced structural changes in the central metal binding region (50-89) 
N50W of prothymosin-α have been investigated. The following CD studies were carried out. 
1.2 A. Zn
2+
 induced structural changes in prothymosin-α(50-89)N50W observed by CD 
Spectroscopy 
The far-UV CD spectrum of prothymosin-α (50-89)N50W in 50 mM phosphate buffer was 
recorded at pH 7.5 and at room temperature. The pH and temperature were kept consistent with 
CD runs of the full length protein collected by Uversky et al. so the results can be directly 
compared (43). The concentration of the peptide used was 0.5 mM and the spectra were collected 
in the wavelength range of 190-260 nm. The peptide exhibits a maximum in the CD spectrum at 
about 220 nm and a minimum at 198 nm which is consistent with random coil conformers. With 
the addition of Zn
2+
 a significant gain in negative ellipticity around 200 nm and a negative 
shoulder around 222 nm were observed suggesting Zn
2+
 induced formation of secondary 
structure in the peptide. The negative shoulder at 222 nm is a characteristic wavelength of α-
helix fomration in proteins.  Figure 3.10A represents CD spectra of Protα(50-89)N50W peptide 
titrated with Zn
2+
. Figure 3.10B represents the corresponding photomultiplier tube (PMT) high 
voltage values HT [V]. As recommended by Jasco, 400 V was selected as the threshold beyond 
which data may be considered excessively noisy and thus unreliable. This occurs at 
approximately 198 nm for all the CD spectra collected in this study. It should be noted that there 
is an isodichroic point at approximately 206 nm indicating a two-state transition. The peptide 
reached saturation at approximately 75 eq of Zn
2+
 which is same as observed for the full protein 
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(43). This supports the conclusions that majority of the metal added binds to the central 50-89 
region.  
 
Figure 3.10: A. Zn
2+
 induced structural changes in Protα(50-89)N50W far-UV CD spectrum. B. 
Corresponding HT[V] shown for peptide with minimum and maximum concentrations of Zn
2+
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(the HT[V]  of spectra recorded with all other concentrations of Zn
2+
 lie within the minimum and 
maximum HT[V] range shown here). 
1.2 B. Temperature-dependent structural changes in prothymosin-α(50-89)N50W 
Initially, the far-UV CD spectra was recorded for Protα(50-89)N50W in 50 mM phosphate 
buffer at physiological pH and room temperature (25 
o
C) to assess its structure. The CD 
spectrum of the peptide had a maximum at 220 nm and a minimum at 198 nm which indicated a 
random coil conformation. The temperature dependence of the secondary structure of the protein 
was investigated from 20 to 80 
o
C.  The data shows that with increasing temperature there is a 
gain in negative ellipticity around 222 nm and loss at around 200 nm which is consistent with the 
assessment that the peptide is attaining structure when heated. A negative ellipticity at 222 nm is 
a characteristic feature seen for α-helixes of proteins. This data suggests a heat-induced folding 
of the Protα peptide chain into an α-helical structure.  
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Figure 3.11: Far-UV CD spectrum of Protα(50-89)N50W collected in 10 oC increments. The 
spectrum shows the peptide adopts structure with increasing temperature.  
Subsequently, temperature dependence of Protα-Zn complex was observed. 50 eq of Zn2+ was 
added to the peptide sample and the peptide-metal sample was heated from 20 to 80 
o
C at 10 
o
C 
increments.  Figure 3.12 shows similar changes in ellipticity of the spectrum as observed in 
Figure 3.11. There is a gain in ellipticity at 222 nm and loss at 200 nm with increase in 
temperature. This data suggests that the peptide attains structure in the presence of Zn
2+
 when 
heated. 
 
Figure 3.12: Far-UV CD spectrum of Protα(50-89)N50W with 50 eq of Zn2+ heated from 20-80 
o
C in 10 
o
C increments. The spectrum shows the peptide adopts structure in the presence of 50 eq 
of Zn
2+
 and with increasing temperature. 
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An overlay of spectra collected at different temperatures (20-80 
o
C) with peptide (only heat) and 
spectrum collected at respective temperatures with peptide and 50 eq of Zn
2+
 (heat and metal)  
showed that the peptide has extremely similar structures in both the cases. However, the amount 
of folding is less in Zn
2+
 present sample. 
 
Figure 3.13: Far UV CD spectra of Protα(50-89)N50W at 60 oC with and without Zn2+. The 
spectral overlay shows that the peptide adopts an overall similar structure in both the cases. 
1.2 C. Zn
2+
 induced structural changes in the polyglutamic acid sequence 
The structural changes in acidic peptides in the presence of Zn
2+
 have been thought to solely 
occur due to electrostatic interactions between Zn
2+
 and negatively charged residues in the 
peptides. We hypothesize that the ionic radius, high charge density, and sequence specificity of 
Zn
2+
 also plays an important role in the specificity of metal binding in the protein. To test the 
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hypothesis we synthesized a polyglutamic acid sequence of same length as Protα(50-89)N50W 
peptide (Sequence 3.1). The polyglutamic acid was designed in a way that residues that are 
found important in Protα(50-89)N50W were retained. The tryptophan at the N-terminal end of 
the peptide helps to measure concentration on UV. The KR residues at the C-terminus are found 
to be important for Protα(50-89)N50W activity. It was reported that Zn2+ binds specifically to 
polyglutamic acid (42). However, the study does not say if the binding induces a structural 
change. 
The CD spectrum of polyE sequence exhibited a maximum at 220 nm and minimum at 198 nm 
which is consistent with random coil conformation. With the addition of large molar excess of 
(200 eq) Zn
2+
 to the peptide, there was no significant structural change observed. These results 
support the idea that high charge of Protα(50-89)N50W is not the sole factor responsible for the 
folding of the peptide in the presence of Zn
2+
. The conformational change induced by Zn
2+
 
binding is sequence specific.  
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Figure 3.14: Far UV CD spectrum of polyglutamic acid in the presence and absence of Zn
2+
. 
The peptide was treated with large molar excess of Zn
2+
 (200 eq.). 
 
Over 50% of Protα(50-89)N50W comprises Asp and Glu and differs significantly from the 
polyglutamic acid sequence in terms of charge. The polyglutamic acid sequence has a greater 
overall charge than Protα(50-89)N50W which might inhibit folding based on increased 
electrostatic repulsion. A scrambled sequence of Protα(50-89)N50W (sequence 3.3) with same 
amount of overall negative charge as the peptide was synthesized and the structural 
characteristics of the sequence were studied in the presence of Zn
2+
.  
Ac-EEDEEEEKDEEAGDEEEDEERGGEEAGEVGEEEDESETG-NH2 
Sequence 3.3: Scrambled Protα(50-89)N50W sequence. The net charge of sequence remains the 
same as the peptide.  
 
Figure 3.15: Far UV CD spectrum of scrambled sequence in the presence and absence of Zn
2+
. 
The peptide was treated with large molar excess of Zn
2+
 (200 eq.). 
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Aggregation or self-association is a characteristic property of denatured proteins (24–29), and it 
has been shown that in some cases association induces more structure and stability in partially-
folded intermediates (28)(29). To be sure there was no aggregation in any of the CD runs the far 
UV CD spectra of Protα(50-89)N50W at 25 oC, 80 oC and back at 25 oC were collected (Figure 
3.16). The two spectra obtained at 25 
o
C before and after heating the sample overlay on each 
other indicating that the heat induced structural changes in the peptide are reversible and no 
aggregation occurred.  
 
Figure 3.16: Far UV CD spectra showing that the secondary structural changes formed on 
heating and cooling of the peptide are reversible. There was no aggregation of the peptide 
observed. Note, that the two spectra collected at 25 
o
C are identical so the blue trace is overlaid 
by the green trace. 
Discussion 
The spatial structure of a protein molecule is often maintained by interaction with specific 
ligands (117). This is true for Protα also. The data shown in literature tells us that zinc is a 
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specific ligand for human Protα and causes adoption of secondary structure in the protein upon 
binding (48). The interaction of Protα and Zn is said to be specific, since of the several divalent 
cations (including Ca
2+
, Mg
2+
, Mn
2+
, Cu
2+
, and Ni
2+
) examined only Zn
2+
 showed the ability to 
induce substantial structural rearrangement in Protα.  
Moving a step forward, an NMR study on Zn
2+
 binding of Protα has revealed that the 48-110 
region of the protein is the Zn
2+
 binding region. There is still a need to explore the Zn
2+
 binding 
region of the protein in a more detailed manner to answer several questions left unanswered 
regarding metal binding in IDPs. 
 
A 
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Figure 3.17: Far UV CD spectra of Protα showing Zn2+ titrations in A) 0.05 mM of full length 
Protα showing a change in the secondary structure with increasing concentration of Zn2+ and in 
B) Protα(50-89)N50W showing the similar structural change as the full protein in the presence of 
Zn
2+
 (43, 118).  
 
Figure 3.17 shows that full length Protα and the Protα(50-89)N50W peptide had a random coil 
like conformation at physiological pH and room temperature. When Zn
2+
 was titrated into them 
the spectra for both the samples showed an increasing negative ellipticity at 222 nm which is a 
characteristic of α-helical formation. This suggests that the shape adopted by the full Protα and 
Protα(50-89)N50W as a function of Zn2+ are very similar. Thus the majority of the structural 
change appears to be occurring in the central region due to interaction with Zn
2+
. It was also 
found that the peptide like the full protein reached saturation at 75 eq of Zn
2+
 indicating that 
majority of the Zn
2+
 added to the full protein binds to the central acidic region (50-89). This 
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implies that the metal binding studies carried out using the 50-89 segment of Protα should model 
the full length protein and that the peptide could be used for Zn
2+
 studies instead of the full 
protein.  
 A second environmental factor that was studied here was temperature. A characteristic 
temperature-dependent spectroscopic change has been observed in Protα(50-89)N50W. Studies 
indicate that the peptide undergoes a structural change (similar to what was seen with Zn
2+
 
binding) when heated from 20-80 
o
C both in the presence and absence of Zn
2+
. The temperature 
induced changes of Protα(50-89)N50W were reversible with no detectable association of the 
protein. In other words, we can assume that the observed changes are of an intra- rather than an 
intermolecular character. The effects of elevated temperature may be attributed to increased 
energy to overcome repulsive electrostatic interactions and thereby the peptide experiences a 
collapse indicating folding. 
Both Zn
2+
 and temperature cause Protα(50-89)N50W peptide to adopt structure. Further, the very 
close resemblance of the CD spectra obtained as a function of Zn
2+
 and temperature suggest the 
overall structures in both the cases may be similar.  
To further investigate the nature of Zn
2+
 induced folding the following question was asked: Does 
Zn
2+
 induced folding of Protα occurs due to electrostatic interaction between the protein and the 
metal? To answer this a polyglutamic acid sequence was synthesized and the Zn
2+
 binding of the 
sequence was tested in the presence of large molar excess of Zn
2+
 (200 eq. of Zn
2+
) (sequence 
3.4) . The sequence showed no change in the structure upon addition of metal (Figure 3.14). This 
suggests that having a region with a high net negative charge is not sufficient for Zn
2+
-induced 
structural changes. Thus there is some sequence specificity needed for Zn
2+
-induced structural 
changes to occur in an acidic peptide.  
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The net negative charge of Protα(50-89)N50W is less compared to the polyglutamic acid 
sequence used for our study (sequence 3.5).  
 
Ac-WEVDEEEEEGGEEEEEEEEGDGEEEDGDEDEEAESATGKR-NH2 
Ac-WEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEKR-NH2 
Sequence 3.4: Protα(50-89)N50W (on the top) and polyglutamic acid sequence (on the bottom). 
The negative residues are highlighted in red.  
To match up the overall charge of the sequence with Protα(50-89)N50W CD spectra of a 
scrambled sequence of Protα(50-89) has been obtained in the presence and absence of Zn2+  
sequence (sequence 3.4). The spectra showed that no major structural changes indicating Zn
2+
 
induced structural changes in Protα(50-89)N50W are sequence specific (Figure 3.15). 
Highly negatively charged proteins like Protα are unfolded in large part due to the electrostatic 
repulsion between the negatively charged residues. When an oppositely charged metal cation is 
introduced to the protein the charged side chains on the protein are neutralized and can transfer 
charge to the metal cation, resulting in neutralization of the positive charge on the cation (ligand 
to metal charge transfer, LMCT) (114, 115).  In the case of Protα the same happens and resulting 
in binding of the metal cations.  
However, it may be asked how is it that of all the metals added (Mg
2+
, Zn
2+
, Ca
2+
) and that can 
associate with Protα, only Zn can induce a structural change. So the next question of interest is 
why does the peptide show a structural change selectively with Zn
2+
? Although Mg
2+
, Zn
2+
, Ca
2+
 
are all divalent metal cations and ionic radius of all the three cations fall in the same range the 
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structural change in the peptide occurs only with Zn. Factors that govern selectivity of a metal 
are charge (valence state), ionic radius, and charge accepting ability. All the three metal cations 
(Mg
2+
, Zn
2+
, Ca
2+
) have same charge and similar ionic radius (Mg
2+ 
0.72 Å, Zn
2+ 
0.74 Å, Ca
2+
 
1.0 Å ). So the charge accepting ability of the metal is the only factor in this case that governs the 
selectivity of Zn
2+
 over other metal cations in this case. Hybridization of 3d and 4s orbitals of 
Zn
2+
 increases the charge acceptance ability of Zn
2+
 from the ligand, which is a carboxylate in 
this case. This is due to the fact that the energy of the ligand’s highest occupied molecular orbital 
(MO) is close to that of the lowest unoccupied MO of the metal, thus leading to charge 
neutralization and folding of the protein in the presence of Zn
2+
. In contrast, for other divalent 
metal cations like Mg, and Ca hybridization occurs between s and p orbitals and cannot accept as 
much ligand charge as the hybridized 3d 4s Zn
2+
 orbitals due to the greater energy difference 
(115, 162). 
The stability of the Zn complex compared to the Mg and Ca complexes with the same ligand is 
explained by the binding gas-phase free energies (∆G) for IIA and IIB metals (Mq+ + nH2O→ [M 
(H2O)n]
q+
)
.
 Zn
2+
 complex has a ∆G of -95.4 kcal/mol which is much higher than the binding free 
energies of Mg
2+
  and Ca
2+, thus explaining the higher stability of Zn2+ complexes (162).  
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Figure 3.18: The binding gas-phase free energies of M
q+
 + nH2O→ [M (H2O)n]
q+
 calculated for 
IIA and IIB metals. Note Zn
2+
 has higher ∆G value than Mg2+ and Ca2+ (164). 
 
In summary, the CD studies discussed above have laid ground work to the effort to refine the 
Zn
2+
 binding residues/region in the Protα. Protα(50-89)N50W similar to the full length protein 
undergoes a structural change in the presence of Zn
2+
. The temperature dependent folding of the 
peptide both in the presence and absence of Zn
2+ 
can be attributed to decrease in repulsive forces 
at higher temperature leading to folding of the peptide. By using the polyglutamic acid and 
scrambled Protα(50-89)N50W it was understood that Zn2+ binding and folding of the peptide is 
not solely due to electrostatic attractions between the cation and the peptide but there is sequence 
specificity between them. The selective interactions of the peptide with Zn
2+
 could be explained 
by the higher charge accepting ability of Zn
2+
 from the peptide than other divalent metals and 
stability of Zn
2+
 complexes.   
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                                                                 Chapter 4 
 Zn
2+
 and temperature induced structural changes in Protα(50-89)N50W 
studied using Differential Scanning Calorimeter (DSC) 
 
Section 4.1 Introduction to DSC 
 
Background  
Calorimetry is a primary technique for measuring the thermal properties of materials to establish 
a connection between temperature and specific physical properties of substances and is the only 
method for direct determination of the enthalpy associated with the process of interest (119). 
Calorimeters are used frequently in chemistry (120), biochemistry (121), cell biology (122), 
biotechnology (123), pharmacology (124), and recently in nanoscience (125) to measure 
thermodynamic properties of the biomolecules and nano-sized materials. Among the various 
types of calorimeters, differential scanning calorimeter (DSC) is a popular one. DSC is a thermal 
analysis apparatus measuring the amount of heat absorbed or released by the sample as a 
function of temperature and time. In other words, the device is a thermal analysis instrument that 
determines the temperature and heat flow associated with material transitions as a function of 
time and temperature (126). During a change in temperature, DSC measures a heat quantity, 
which is radiated or absorbed excessively by the sample on the basis of a temperature difference 
between the sample and the reference material (126).  
Calorimetry is particularly applied to monitor the changes of phase transitions (127). Thermal 
transition temperatures (Tt; melting points) of the samples are also determined in solution, solid, 
or mixed phases such as suspensions (128-131). It is also used for the study of biochemical 
reactions, which is named as a single molecular transition of a molecule from one conformation 
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to another (128). In a basic DSC experiment, heat energy is introduced simultaneously into a 
sample cell (which contains a solution with the molecule of interest) and a reference cell 
(containing only the solvent). Temperatures of both cells are raised identically over time. The 
difference in the input energy required to match the temperature of the sample to that of the 
reference would be the amount of excess heat absorbed or released by the molecule in the sample 
(during an endothermic or exothermic process, respectively) (127-129). As a result of the 
presence of the molecule of interest, more or less energy is required to bring the sample to the 
same temperature as the reference; hence, the concept of heat excess comes into the picture 
(Figure 4.1).  
As a powerful analytical tool, DSC is capable of elucidating the factors that contribute to the 
folding and stability of biomolecules. Changes in the capacity of a molecule to take up heat, 
commonly known as heat capacity (Cp) are believed to originate from the disruption of the 
forces stabilizing native protein structure. For example, this includes van der Waals, 
hydrophobic, and electrostatic interactions, hydrogen bonds, hydration of the exposed residues, 
conformational entropy, and the physical environment (such as pH, buffer, ionic strength, 
excipients) (128). Therefore, thermodynamic parameters obtained from DSC experiments are 
quite sensitive to the structural state of the biomolecule. Any change in the conformation, like a 
mutation in the sequence would affect the position, sharpness, and shape of transition(s) in DSC 
scans. 
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Figure 4.1: Experimental setup for a DSC experiment. The amount of heat required to increase 
the temperature by the same increment (∆T) of a sample cell (qs) is higher than that required for 
the reference cell (qr) by the excess heat absorbed by the molecules in the sample (∆q). The 
resulting DSC scans with the reference subtracted from the sample show how this excess heat 
changes as a function of temperature T (K), Temperature, kelvin; ∆H, change in enthalpy; ∆Cp,d, 
change in Cp; Tm, transition and melting point; d, denatured (130). 
 
Basics: 
Heat Capacity:  
As the name implies, heat capacity is a measure of the capacity of any object to take up heat 
energy. At the molecular level, this heat energy will be distributed among the available degrees 
of freedom and partitioned into kinetic energies (related to vibrational, rotational, or translational 
motions) or potential energies (related to changes in inter atomic potential energies, bond 
stretching, bending, breaking, and so forth). It follows that the more ways there are of 
distributing heat energy in a substance, the higher will be its heat capacity. This roughly explains 
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why liquid water has such a relatively high heat capacity; heat energy is diverted into breaking 
residual intermolecular hydrogen bonds rather than raising the temperature. 
Heat capacity is central to fundamental thermodynamics because both the absolute enthalpy (H) 
and the entropy (S) of any object are integral functions of its heat capacity where Cp is the heat 
capacity at constant pressure, T is the absolute temperature, and the integral is taken from 
absolute zero (0 K) to the required temperature. H(0) and S(0) are the zero-point enthalpy and 
entropy, respectively.  
 ( )   ( )   ∫      
 ( )    ( )   ∫(
  
 
)   
Enthalpy: 
The enthalpy of the endothermic or exothermic event is determined by the integration of the area 
under the DSC peak, which is often reported in kcal/mol (131-134). The shape of the thermally 
induced event is described by the width of the transition at half height of the peak (T1/2), 
whereby, the peak is defined by the difference between the lower (TS) and upper boundaries (TL) 
of the phase transition (Figure 4.2). 
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Figure 4.2: A sample endotherm showing Enthalpy, T1/2 and Tm (131). 
Modulated differential scanning calorimetry (MDSC) 
DSC measures the difference in heat flow between a sample and reference as both are subjected 
to a linear change in temperature. The heat flow signal is a combination of 'kinetic' (f(T,t)) and 
'heat capacity' (Cp•dT/dt) responses, i.e. the heat flow from the sample (or reference) is a 
function of both heat capacity of the sample and of any kinetic heat flow component (135). The 
heat flow signal is given as  
  
  
    
  
  
   (   ) 
where Q is the (heat) energy, Cp is the 'thermodynamic' heat capacity (i.e. that due to the energy  
stored in vibrations, rotations and translations of molecular constituents of the sample), T is the  
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absolute temperature and f(t,T) is some function of the time and temperature which expresses the 
calorimetric response of any kinetically controlled chemical or physical phenomena. 
Modulated DSC measures both kinetic and heat capacity in a single experiment by 
superimposing a modulated heating rate on top of a linear heating rate (Figure 4.3). Advantages 
of MDSC include high resolution, high sensitivity, superior sensitivity exhibited by MTDSC to 
measure glass transitions.  
 
Figure 4.3: MDSC temperature profile. The linear change in temperature permits the 
measurement of heat flow while the modulated change permits the calculation of heat capacity. 
Applications 
Considering the ability to measure enthalpy changes and phase transitions, there are multiple 
applications for a versatile tool like DSC. There are several reviews on its application to various 
fields like proteins(136), protein of pharmaceutical interest (137), protein mutations (138), protein-
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ligand interactions (139,140), protein folding (141), nucleotides (138), other macromolecules (142), 
lipids (142-144), drug-lipid interactions (143), and protein-lipid interactions (144).  
DSC in Proteins 
One of the earliest DSC applications was to study thermally induced, cooperative conformational 
changes of small proteins. Protein thermodynamics, during unfolding, is measured as an enthalpy 
change as a function of temperature. The temperature at the maximum point of the Cp curve 
(Tm) represents the macromolecule stability (145-147). DSC based thermal analysis provides 
insight into protein unfolding and forces involved in conformational stability. Protein 
denaturation process is highly cooperative with disruption of many forces and bonds, including 
hydrogen bonds, hydrophobic interactions, and many non-covalent interactions (148). DSC 
allows for the direct study of thermal stability, over a very large concentration range, in the 
absence of light, thus photosensitive proteins such as bovine lens crystallins can be analyzed 
(148).  
A typical DSC data for the heat capacity increment observed upon thermal unfolding of a 
globular protein in aqueous solution is shown below (Figure 4.4) (129). The thermal unfolding of 
globular proteins in water is a classic example, where direct calorimetric (DSC) measurements, 
supported by more indirect methods, show that an overall heat capacity increment (positive Cp) 
is an almost universal characteristic of the unfolding transition (119, 138). The protein shows an 
unfolding endothermic event as the protein unfolds and as the heat energy being applied disrupts 
intramolecular interactions. As the temperature was increased the protein moved from a folded 
state to an unfolded state. The difference in the baseline before and after the melting temperature 
is measured as the heat capacity (Cp).  The heat capacity of the unfolded peptide is significantly 
greater than that of more compact native conformation. 
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.  
Figure 4.4: Typical DSC data for the heat capacity increment observed upon thermal unfolding 
of a globular protein in aqueous solution.  The dotted line shows the overall heat energy uptake 
associated with the actual unfolding transition. The difference in the baseline is measure as heat 
capacity (Cp) (129). 
 
Protein Heat Capacity: 
 
The measurement of heat capacities (Cp) and heat capacity changes (∆Cp) for proteins in dilute 
(<1 mg mL
-1
) aqueous solutions is now relatively straightforward using commercially available 
differential scanning calorimeters (DSC) specifically designed for the purpose, most usually in 
the 0-110 
o
C temperature range (119, 149). Figure 4.5 shows “Typical” DSC data for the thermal 
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unfolding of a simple globular protein in solution at varying pH. The Figure illustrates various 
features that will be considered. 
 
Figure 4.5: Typical DSC data for the unfolding of a small globular protein (lysozyme) in 
solution at various pH values. The increase in area under each endotherm with higher Tm and the 
higher heat capacity baselines after the unfolding transitions are both indications of the 
significant positive ΔCp commonly associated with such processes. (127)  
 
For well-behaved proteins undergoing reversible thermal transitions, the heat capacity curves 
obtained by DSC (Figure 4.5) show several characteristic features. Starting from low 
temperature, the apparent protein heat capacity gradually increases until the onset of thermal 
unfolding, accompanied by a sharp peak in Cp corresponding to an endothermic unfolding 
transition. The peak of the transition gives the midpoint temperature (Tm), and the area under the 
transition gives the enthalpy of unfolding (ΔHunf) at this temperature. The heat capacity of the 
protein above the transition, once it has returned to baseline, is typically higher than would be 
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anticipated from extrapolation of the low-temperature baseline. Consequently, the thermal 
unfolding shows a positive heat capacity change, ΔCp. This is also indicated by the marked 
increase in the area under the transition peak (ΔHunf) with increasing Tm. 
The sort of behavior shown here is usually only seen for relatively small proteins undergoing 
reversible unfolding, typically at low pH and low concentration. Unfortunately, most proteins do 
not behave that way, especially near neutral pH. Denaturation of unfolded protein is frequently 
accompanied by aggregation or other irreversible effects (150). The DSC study on Protα(50-
89)N50W would set the stage for introducing a new alternative method to study conformational 
changes in IDPs in the presence  and absence of metal cations. 
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Section 4.2 Research Strategy 
 
Protα lacks a native tertiary or secondary structure according to the usual criteria provided by 
NMR, CD, and SAXS (43, 60). To compliment the CD data the Protα(50-89)N50W peptide has 
been studied using Modulated Differential Scanning Calorimetry (MDSC).    
Specific Aim: The goal of this study was to investigate the conformational stability of Protα(50-
89)N50W during the process of thermal denaturation in the presence and absence of zinc ions, 
Zn (II), and to estimate the thermodynamic parameters of protein unfolding and zinc binding 
with the purpose of obtaining a better understanding of the Protα(50-89)N50W/zinc interaction. 
Based on temperature dependent CD studies we hypothesize the peptide undergoes an unfolded 
to folded transition upon heating in DSC. Our first aim was to look at the conformational 
changes of the peptide itself (metal free) upon heating. The subsequent set of experiments was 
carried out by the addition of 50 eq. of Zn
2+
 to the peptide.  
Experiments:  
All DSC measurements were carried out on TA Instruments Q2000 calorimeter. An optimum 
concentration of the peptide that gives a good signal on DSC has been determined to be 50 
mg/ml. The empty sample pans were weighed and a 10 µl sample of Protα(50-89)N50W (50 
mg/ml) dissolved in 50 mM phosphate buffer at pH 7.2 was placed in a hermetically sealed t-
zero aluminium pans. N2 is used as a purge gas and is preheated for 30 mins to ensure uniform 
temperature environment. DSC measurements were performed by placing the peptide in the 
sample pan and buffer in the reference cell at a scan rate of 1 
o
C/min from 25 to 80 
o
C under 
modulated conditions. 50 mM phosphate buffer at pH 7.2 was used as buffer. Thermograms of 
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the peptide with and without Zn
2+
 in the sample were obtained. The thermodynamic parameters 
like enthalpy, melting temperature, and heat capacity were obtained.  
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Section 4.3 DSC Measurements 
 
1.3 Investigation of the structural changes in the Protα(50-89)N50W upon thermal 
denaturation  using differential scanning calorimetry (DSC) 
MDSC thermogram of prothymosin-α (50-89 N50W) in 50 mM phosphate buffer was recorded 
at pH 7.5. The temperature was raised from 25–80oC. The concentration of the peptide used was 
50 mg/ml. The peptide exhibits an exothermic event indicating collapse into a more compact 
form and that the new structure is forming intramolecular interactions. Hence, heat is given off 
as new intramolecular interactions are formed (Figure 4.6).  
 
Figure 4.6: The thermal induced folding of Protα(50-89)N50W peptide monitored by DSC 
under modulated conditions. Blue and green traces indicate heat capacity and heat flow 
respectively. The heat capacity of the peptide folding is 0.9748 J/(g*(
o
C)). 
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With the addition of 50 eq. Zn
2+
 the peptide continued to show an exothermic event which can be 
interpreted as a folding event. However, the transition is broadened in the Zn
2+
-loaded peptide 
suggesting a smaller, temperature induced structural rearrangement. Figure 4.7 shows the 
thermogram for Zn
2+
-loaded peptide.  
 
Figure 4.7: The thermal induced folding of 50 eq. Zn
2+
-loaded Protα(50-89)N50W peptide 
monitored by DSC under modulated conditions. Blue and green traces indicate heat capacity and 
heat flow respectively. The heat capacity of the peptide folding is 0.7787 J/(g*
o
C). 
 
The mid transition temperature, enthalpy, and specific heat of the peptide before and after Zn
2+
 
addition are listed in the table below. These results will be addressed in the discussion section 
below. 
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Sample Name Mid-transition       
Temperature (
o
C) 
∆H (kJ/mol) ∆Cp (J/g 
o
C) 
 
Protα(50-89)N50W 
 
 
Protα(50-89)N50W  
with 50 eq. of Zn
2+
 
 
 
63.66 
 
 
60.63 
 
-68.7 
 
 
-50.2 
 
-0.9748 
 
 
-0.7787 
 
Table 4.1: The thermodynamic parameters: mid-transition temperature, enthalpy, and heat 
capacity for the peptide both in the presence and absence of Zn
2+
 
 
Discussion: 
The temperature dependent profile of Protα(50-89)N50W in the presence and absence of Zn2+ 
was studied using DSC. The peptide showed an exothermic event in the presence and absence of 
Zn
2+
. Literature on DSC studies of folded proteins has explained an endothermic event as a 
defining feature of protein unfolding in solution resulting in a positive ∆Cp and an exothermic 
event as protein aggregation resulting in low heat capacity than the folded form of the protein 
(Figure 4.8) (152). 
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Figure 4.8: DSC data for thermal denaturation of yeast phosphoglycerate kinase, illustrating 
exothermic baseline distortion and heat capacity decrease caused by irreversible precipitation of 
unfolded protein (152). 
 
However we strongly believe that the exothermic event seen in Protα(50-89)N50W peptide both 
with and without Zn
2+
 in the sample does not correspond to protein aggregation because of three 
reasons. The first is the temperature dependent CD runs on the peptide showed a reversible event 
indicating no aggregation of the peptide upon heating and cooling. The second point of support is 
the Cp value. The Cp value of an aggregated peptide shows a much lower value after heating 
compared to the folded peptide (Figure 4.9). In the case of Protα(50-89)N50W peptide an 
extrapolated line shows a continuous trend, whereas there is an abrupt and large change in Cp 
upon aggregation (note discontinuity of the base line in Figure 4.9). Lastly, given the high 
negative charge of the peptide aggregation is highly unlikely. 
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Figure 4.9: DSC thermogram of the thermal aggregation of insulin in solution. The inset shows 
the more typical thermogram seen for protein unfolding (without aggregation). Note the 
decreased heat capacity for the fibril state (arrow) (152). 
 
The exothermic event in the peptide can be explained as the Protα(50-89)N50W peptide 
behaving opposite way a folded protein behaves. That is an unfolded protein unlike the folded 
protein collapses and adopts a structure upon heating. The DSC data of Protα showed an 
exothermic event indicating protein folding both in the presence and absence of Zn
2+
. These 
results coincide well with the CD temperature studies. In temperature dependent CD studies of 
the peptide the shape of the spectra is congruous with increasing structure upon heating from 20-
80 
o
C both in the presence and absence of Zn
2+
.  
In the presence of Zn
2+
 the folding event is broadened and the ∆H value is less negative 
indicating decreased cooperative folding in the protein compared to the no Zn
2+
 sample. A 
decreased folding of the Zn
2+
 loaded peptide can be explained by decreased co-operativity 
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associated with the exothermic event implying that Zn
2+
 disrupts or interferes with the natural 
folding/organization of the peptide when heated. This may be due to the fact that Zn
2+
 is now 
bound to the peptide and occupying sites on peptide backbone that are important during peptide 
folding by heat or Zn
2+
 pre-organizes the peptide and the folding has taken place simply due to 
the addition of Zn
2+
 so there is less folding that can occur upon heating when compared to the 
apo-peptide. Additional evidence is seen when the enthalpy associated with this event is 
examined. A decreasing enthalpy indicates that there may be less intra or inter molecular 
interactions when Zn
2+
 is present (151).  
One would expect that the peptide folding is indicative of buried hydrophobic surfaces.  
However, for acidic peptides like a Protα(50-89)N50W  a negative correlation exists between the 
buried surface area and the combination of net high charge and low hydrophobicity (16, 116, 151). 
If the folding in the peptide is real, the deviation of the peptide from paradox (unfolding upon 
heating is the regular trend) needs a deeper insight.   
The literature available on DSC of proteins so far has not explained a negative ∆Cp value. The 
exothermic event has been treated only as protein aggregation.  A literature study using DSC on 
a family of natively disordered fragments from Escherichia coli thioredoxin has reported heat 
capacity analysis of fragments of thioredoxin protein. Most of the fragments analyzed showed a 
positive ∆Cp indicating that the fragment behaves like a globular soluble protein, which buries 
its hydrophobic patches to a greater extent than the polar ones. However, a fragment (32-108) 
showed negative ∆Cp values throughout the whole temperature range and for fragment 51-108 
the ∆Cp becomes negative beyond 66 oC. The study has left the negative ∆Cp value seen for 
fragment 32-108 unexplained.  
 
 
107 
 
To conclude spin lattice relaxation (T1) measurements at different temperatures on NMR and a 
means of digging deeper into analysis of temperature dependent profile of the peptide is essential 
to obtain any further information about temperature dependent folding of Protα. 
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Chapter 5  
Spin-lattice relaxation measurements of EDTA and Zn2+  
Section 5.1 Introduction on NMR Relaxation 
 
NMR is one of the most common methods used for the biophysical characterization of protein-
metal interactions (152). The first step to obtain structural information by NMR measurements is 
the assignment of resonances. In the case of IDPs like Protα this can be challenging due to 
extensive signal-overlap and exchange broadening of amide proton signals. For structured 
proteins, resonance assignment is done with a set of spectra, typically 
15
N, and 
1
H resolved triple 
resonance experiments that contain information linking 
1
HN, 
13Cα, 13Cβ, 13Cγ, and 15N chemical 
shifts. Figure 5.1 shows sample 
1
H-
15
N HSQC spectra. The figure shows how a well resolved 
spectrum (on the left) of a folded protein differs from a signal overlapped spectrum (on the right) 
of the same protein in a denatured state. The sequence homogeneity in IDPs results in chemical 
shift degeneracy and signal overlap demanding a different approach. A measure of relaxation 
times is a possibly method of approach to study dynamics and metal binding in IDP’s. A detailed 
strategy on how this type of study can be applied to Protα(50-89)N50W will be discussed in 
chapter 6.  
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Figure 5.1: 1H–15N HSQC spectra of uniformly 2H-13C-15N labeled WT-Interleukin-1 showing 
signal dispersion on the left and overlap on the right upon denaturation with 5.2 M urea (153). 
 
Relaxation measurements:  
Relaxation of a nucleus is defined as a process by which excited nuclear magnetization vector of 
the selected nucleus loses the extra energy and returns to equilibrium. There are two types of 
relaxations; spin-lattice (T1 or longitudinal relaxation or relaxation in Z-axis) and spin-spin (T2 
or transverse relaxation or relaxation in x-y plane). T1 relaxation corresponds to the process of 
establishing the normal Gaussian population distribution of α and β spin states in the magnetic 
field. T2 is loss of phase coherence among nuclei. T2 is less than or equal to T1 since return of 
magnetization to the z-direction inherently causes loss of magnetization in the x-y plane. 
Relaxation rate is inverse of relaxation time.  
 
      
R is relaxation rate, T is relaxation time. 
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Spin-lattice relaxation 
When molecules absorb electromagnetic radiation they are transferred from lower energy states 
to higher energy states. This leaves the system out of equilibrium, and the system must undergo 
transitions from the upper states to lower states to get back to equilibrium. This process is 
illustrated in Figure 5.2. 
For protons, the energy level diagram has two energy levels, the lower state with protons "spin 
up", or aligned with the external field, and the higher state with protons "spin down", or aligned 
against the external field. Electromagnetic radiation in the radiofrequency region of the spectrum 
causes protons to "flip", or jump to higher energy levels. The process whereby the system returns 
to equilibrium involves spin flips to return to the lower energy state, and the excess energy is lost 
to the surroundings in the form of heat. The surroundings in magnetic resonance experiments are 
called the "lattice", therefore the name spin-lattice relaxation. The characteristic life-time of a 
spin in the upper state is called the spin-lattice relaxation time T1. T1 is the average length of 
time that a proton remains in the excited state or higher energy level. The spin-lattice relaxation 
time is also called the longitudinal relaxation time. 
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Figure 5.2: Basic representation of absorption and spin-lattice relaxation for spin I=1/2 system 
 
An easy way to visualize the process is shown in Figure 5.3, which illustrates an older method 
for measuring T1's called "saturation recovery." At left the spins start at equilibrium. The 
radiofrequency source is then turned on, which causes transitions between the two levels. After 
the source has been on for a short time the populations (number of spins in a given level) of the 
two levels are equalized. With equal populations, the two levels are said to be saturated and will 
no longer give a resonance signal. The source is then turned off, which allows the nuclei to 
return to equilibrium some time later. A good rule of thumb is that it takes about 5xT1 for the 
system to return to equilibrium (154).  
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Figure 5.3: Saturation recovery method for spin-lattice (T1) measurement. Irradiation leads to 
saturation and after the radiation source is turned off the system begins to return to equilibrium. 
 
The population ratio in the α and β spin states is given by the Boltzmann equation that relates the 
population ratio to the energy difference between the two states ( E) and the absolute 
temperature (154).  
        
    (    ) (1) 
Where Nβ and Nα stand for population of nuclear spins in α and β states, ∆E is the energy 
difference between the two spin states, KB is the Boltzmann constant, and T is the temperature in 
Kelvin. 
The NMR signal is caused by the net magnetization of the spins Mz, which is proportional to the 
difference in the populations of the two levels: 
                                 Mz = (# spins in lower state) - (# spins in upper state) 
Spin-lattice relaxation is a first order kinetic process given by Bloch equation: 
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Where Mz is the magnetization at time t and Mo is the magnetization at equilibrium. Integrating 
equation 2 for the recovery from saturation gives: 
      
      (3) 
Spin-Spin relaxation 
The spin–spin relaxation is the mechanism by which  the transverse component of 
the magnetization vector, exponentially decays towards its equilibrium value of zero in nuclear 
magnetic resonance (NMR) and magnetic resonance imaging (MRI). 
Spin-spin lattice is not discussed in detail as the data focuses on T1 measurements and T2 will not 
influence this study. 
Measurement of T1 by spin-inversion recovery 
For T1 relaxation to occur there must be magnetic field fluctuations in the x,y direction. Such 
fluctuations are most effective when they occur at the Larmor frequency (νo). T1 relaxation is 
thus field dependent, since νo varies with the field. The principal source of fluctuating magnetic 
fields in most molecules is molecular motion. The motion of a molecule can be characterized by 
a correlation time, τc (s). The correlation time is the average time that a molecule spends in a 
given orientation (154). Large molecules tumble slowly and therefore have long τc. Small 
molecules tumble very rapidly and therefore have short τc.  
The step by step procedure of how T1 relaxation is measured (Figure 5.3) by spin inversion 
recovery experiment will be discussed in detail. When a system is in equilibrium it has more 
spins in α state than in β state. When a pulse sequence (180o-t-90o) is applied to the nuclei it 
causes inversion of spins in the α and β states (see top of Figure 5.4 for visual representation of 
this pulse sequence). This creates a population inversion where there are more spins in the higher 
state than in the lower state.  
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Figure 5.4: 
13
C NMR inversion recovery experiment on terpinen-4-ol (155). 
 
The spectrum of the system in the inverted state contains all negative peaks (shown at t1 = 0.03s 
in the Figure 5.4). For short delayed times (t1) values, the population remains inverted and peaks 
in the spectrum remain negative. For longer delayed times, the system reaches equilibrium and 
the spectrum starts to show positive peaks. At even longer delay times the system has reached 
equilibrium prior to the second pulse and typical NMR spectrum is recorded. The spectra for 
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various delayed times are plotted on the same chart, giving the so-called partially relaxed spectra 
for the system, as shown in Figure 5.5. Note that the different carbons in the molecule relax at 
different rates. This is due to their local environment and molecular motion. The point where a 
peak changes from negative to positive is a rough measure of the T1, and t = T1 ln 2. 
To be more appropriate the T1 value for each chemical environment can be obtained by fitting 
the peak intensity of each peak to the equation: 
  (     )    (   )   
 
  
 
(4) 
Notice that taking the natural logarithm (ln) of both sides of the above equation would give 
ln(Mz) = ln(Mo) – t/T1 , the difference here is that the signal for a small t is negative.  
 
 
Figure 5.5: Measurement of T1 by inversion recovery of diphenyl ether (155). 
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There are several mechanisms by which molecular motions can influence nuclear relaxation 
(154): direct dipole-dipole interactions with nearby magnetic nuclei (DD), chemical shift 
anisotropy effects (CSA), quadrupole-electric field gradient interaction (QR) and rapid 
modulation of J-coupling (SC). In addition to molecular motion, rotational transitions can also be 
the source of fluctuating magnetic fields (SR). 
Dipole-Dipole Relaxation (DD) 
The direct dipole-dipole coupling interaction is very large (often kilohertz) and depends on the 
strength of the dipolar coupling, on the orientation/distance between the interacting nuclei and on 
the motion. The equation below accounts for the relaxation due to the dipole-dipole interactions. 
   (
 
  
 
)     
    
  ( )      
(5) 
Where h is Planck’s constant, γH and γX are the gyromagnetic ratios of proton and any other 
nucleus being relaxed, r is the distance between proton and other nucleus being relaxed, τc is the 
correlation time. This coupling is not seen in non-viscous solutions because it is averaged to zero 
by tumbling of the molecule. However, as the molecule tumbles in solution the dipole-dipole 
coupling is constantly changing as the vector relationships change. This creates a fluctuating 
magnetic field at each nucleus. To the extent that these fluctuations occur at the Larmor 
precession frequency, they can cause nuclear relaxation. This relaxation mechanism is 
particularly important for molecules containing protons because proton has the highest 
gyromagnetic moment of common nuclei; it is the most effective nucleus for causing DD 
relaxation. DD relaxation is the principal relaxation pathway for carbons with directly attached 
protons. 
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DD relaxation shows very strong distance dependence, and operates most effectively between 
directly bonded nuclei. At the usual spectrometer frequencies, small molecules (MW <1000) are 
tumbling too fast for the most effective relaxation (τc is too short). Thus the more rapidly a 
molecule or part of a molecule tumbles, the less effective DD relaxation is, and the longer T1 
becomes. The motion of large molecules (e.g. proteins) is slower compared to small molecules 
(τc is too long), and have the opposite relationship between molecular motion and T1 (i.e., 
relaxation is more effective when the molecule moves faster). For 
13
C NMR, dipole relaxation by 
directly attached protons (if any are present) is the principal relaxation mechanism. Thus 
quaternary carbons will have long relaxation times (hence their low intensity under normal 
conditions of spectrum acquisition), methine (CH) groups will have shorter relaxation times, and 
methylene (CH2) groups still shorter, by approximately a factor of two. Methyl (CH3) groups 
show highly variable T1 values but can be very short as seen in Figure 5.4. They usually move 
much more rapidly than the rest of the molecule, and thus undergo less effective DD relaxation, 
but this may be complicated by SR relaxation. 
 
Chemical Shift Anisotropy (CSA) 
 
The chemical shift of a nucleus is a function of the orientation of the molecule with respect to the 
magnetic field (i.e. it is a tensor quantity), provided the nucleus is not at the center of tetrahedral 
or octahedral symmetry. As the molecule tumbles in solution, the chemical shift (and hence the 
magnetic field at the nucleus) is constantly changing and causes relaxation of the nucleus. The 
relaxation rate is proportional to the square of the gyromagnetic ratio and of the magnetic field 
strength, as well to the chemical shift anisotropy. The equation below applies to cylindrically 
symmetric molecules 
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  (   )  
 
  (   )
 
 
  
        
 (    )   
(6) 
B is the magnetic field, γ is the gyromagentic ratio, τc is correlation time, σ is chemical shift 
anisotropy (CSA) (if symmetrical CSA = 0). 
The mechanism is never seen for protons, and is seen for carbon only when there are no attached 
protons (e.g., carbonyl compounds other than aldehydes and formates). Anisotropy is a property 
of p-orbitals. An s-orbital is isotropic hence why protons cannot access this mechanism of 
relaxation. Nuclei such as 
199
Hg, 
119
Sn and 
77
Se with large chemical shift ranges are relaxed 
largely or entirely by the CSA mechanism. Operation of this mechanism causes reduction or loss 
of NOE effects. 
Quadrupole Relaxation (QR) 
This mechanism operates for spin >½ nuclei only, and only for nuclei which are not at the center 
of tetrahedral or octahedral symmetry. Spin ½ nuclei can be considered to have spherical charge 
distributions, but for spin >½ nuclei the charge distribution has the shape of an oblate or prolate 
spheroid. Electric field gradients in such molecules exert a torque on the quadrupolar nuclei. 
Tumbling of the molecule can then initiate transitions among the spin states (there is "friction" 
between the nucleus and the surrounding electrons, the "quadrupole coupling constant". The 
effectiveness of this relaxation mechanism is critically dependent on this coupling. If Q is small 
(as for 
2
H and 
6
Li) the nucleus behaves like a spin ½ nucleus, if it is large the nucleus can have 
very short T1, and observation can be very difficult. 
 
Spin Rotation (SR).  
A local magnetic field is generated by the circular motion of electrons in a rapidly rotating 
molecule (or part of a molecule, such as a methyl group). The magnitude of this field changes 
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when the rotational energy levels change as a result of molecular collisions. These changes, if 
they occur at the Larmor precession frequency, can cause relaxation of nearby nuclei. The 
correlation time for SR relaxation is not molecular motion, but the lifetime of rotational quantum 
levels. Small molecules or freely spinning portions of larger molecules without other efficient 
relaxation mechanisms undergo SR relaxation. Better SR relaxation (shorter T1) occurs at higher 
temperatures. The SR mechanism has been detected for methyl groups, and for quaternary 
carbons of small molecules which do not have other effective relaxation mechanism. Operation 
of this mechanism causes reduction or loss of NOE effects. 
 
Nuclear Overhauser Effect (NOE) 
When a proton is close in space to another proton (or any other nuclei with spin > 0), their 
magnetic dipoles interact. This interaction is distinct from J coupling, which is not a through 
space effect, but is mediated by polarization of bonding electrons in the molecule. The NOE 
effect is the change in spin state population of one proton (or other nucleus) when another 
magnetic nucleus close in space is irradiated. NOE is a consequence of DD relaxation where one 
nucleus is causing T1 relaxation in the other and can be used to determine intra molecular 
distances. 
The effects of these different relaxation mechanisms will be observed and reported in Zn
2+
-
EDTA studies. 
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Section 5.2 Research Strategy 
The main question to be addressed by the proposed studies regarding zinc (Zn
2+
) binding to the 
protein (Protα) is, if there is a single localized binding site or are there several degenerate 
binding sites? This might provide insight into how intrinsically disordered proteins that lack the 
most common ligands cysteine and histidine, bind Zn
2+
 and helps in the determination of zinc-
binding residues in Protα. The results from NMR might also provide insight into CD and DSC 
results.  
2D NMR experiments have revealed that the central segment of Protα is the Zn2+ binding region 
(60). However because of the lack of heterogeneity in the central segment of the sequence the 
study could only determine the general metal binding region and not the specific metal binding 
sites/residues in the protein. 
The fact that Protα lacks the most common Zn2+ binding residues cysteine and histidine the next 
common ligands for Zn
2+
 in Protα are carboxylate side chains of aspartic and glutamic acid. 
Relaxation measurements with selective 
13
C isotope labeling of 
13
CO groups in aspartic and 
glutamic acid is our method of choice to investigate Zn
2+
 binding in Protα.  
13
C relaxation offers a number of advantages for carbonyl relaxation measurements. It allows 
functionally important carbonyl groups accessible for relaxation measurements (155). Examples 
of such groups include backbone 
13
COs of residues preceding proline (Pro); such residues are of 
biological interest since Pro-rich sequences often comprise the docking sites mediating protein–
protein interactions (156). Further examples are the side-chain 13COs of aspartate (Asp) and 
glutamate (Glu) residues, which participate in electrostatic or hydrogen bond interactions 
underlying the catalytic mechanisms of therapeutically important enzymes, such as DHFR (157) 
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and HIV–protease (158). All of these 13COs lack an adjacent scalar-coupled 15N–1H moiety, and 
are therefore beyond the grasp of HNCO-based approaches (159). A second advantage of 
13
C-
detection is that the pulse schemes require fewer extended spin–echo durations, which are 
typically needed for coherence transfer across small heteronuclear scalar couplings. This means 
less time spent in the transverse plane, and less signal loss for nuclei plagued by short transverse 
relaxation times. A third advantage is that peptide linkages that are undetectable via 
1
H-
15
N 
HSQC-based relaxation experiments because of severe exchange 
1
H and 
15
N broadening may 
nevertheless be observable via 
13
CO-detected methods. Finally, 
13
C-detection obviously avoids 
artifacts associated with water suppression and radiation damping. The latter can pose practical 
problems for 
1
H-detected relaxation pulse schemes that involve significant proton pulsing to 
average out cross-correlated relaxation effects and J-coupling artifacts. 
In order to address the core research question our first objective will be to determine the efficacy 
of 
13
C relaxation studies as a means to detect direct Zn
2+
 coordination. This will be achieved 
using a simple and inexpensive model complex. It lays the ground to perform relaxation 
measurements on a series of 
13
C labeled Protα peptides in the presence and absence of Zn2+.  
We have chosen ethylenediaminetetraacetic acid (EDTA) as the model compound for the proof-
of-principle 
13
C relaxation studies (Figure 5.6). EDTA is a well characterized metal chelator with 
high affinity for Zn
2+
 (Kd = 10
-16
 M) (160) and chelates in 1:1 ratio of Zn2+:EDTA. 
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Figure 5.6: EDTA- Zn
2+
 complex showing the ligand coordination and geometry. 
The reason for choosing EDTA as a model is because of its strong affinity for Zn
2+
, structural 
similarity to the side chain of glutamic acid, and ready availability. The Zn
2+
-EDTA ion complex 
is stable this is probably due to the size of the chelate ring. For an assessment of Zn
2+
-EDTA 
complexes, several kinds of relaxation data, in the first instance T1 for EDTA with and without 
Zn as a function of magnetic field strength and temperature were acquired. From these 
measurements different contributions to T1 (T1 (SR), T1 (NOE), T1 (DD), and T1 (CSA)) have been 
calculated. In order to keep the experimental conditions consistent with Zn
2+
-Protα studies the 
spin-lattice (T1) relaxation times of EDTA with and without Zn
2+
 in 50 mM phosphate buffer, pH 
7.4 using 400 MHz NMR were measured. In particular, we focused on the T1 values for the 
carbonyl carbons as these are the closest spin-active nuclei to the Zn
2+
 ion and thus should be 
most sensitive to its presence or absence. However, the relaxation times for every carbon in 
EDTA were measured.  
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Figure 5.7: A) Structure of EDTA with one of its four carbonyl carbons indicated by red arrow, 
lateral carbon indicated with a purple arrow, and central carbon indicated with a green arrow. B) 
Structure of glutamic acid in the context of a peptide sequence. The carbonyl carbon of its 
carboxyl side chain is indicated with a red arrow.  
Expected Results 
The T1 of 
13
CO group on EDTA should take longer time to relax when there is no Zn
2+
 in the 
sample.  This is because the motion of the CO group is free and rotates faster when there is no 
Zn
2+
 in the sample. However in the presence of the Zn
2+
 the motion of the CO group is restricted 
and thereby decreases the relaxation time.  
Spin-lattice relaxation measurements were made and the contribution of different relaxation 
measurements like CSA, DD to the total relaxation were determined. In the case of carbonyl 
carbon CSA and SR are the dominating mechanisms, as there are no protons to promote the DD 
mechanism. For lateral and central carbons that have protons attached DD and SR are the 
dominant relaxations mechanism. Ultimately the correlation times of three carbons with and 
without Zn
2+
 in the sample were obtained. This study was carried out on 400 and 500 MHz and 
at three different temperatures (25 
o
C, 40 
o
C, 50 
o
C). 
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Effect of temperature on correlation times τc 
The correlation times of the carbons will go down with increase in temperature irrespective of 
presence or absence of Zn
2+
 in the sample. This is attributed to increase in the molecular motions 
at high temperatures.  
Effect of Zn
2+
 on correlation times 
The Zn
2+
 added samples are expected to have longer correlation times irrespective of the 
temperature because of the restricted motion  
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Section 5.3 Relaxation rates of the carbonyl carbon 
Sample preparation 
60 mM of EDTA was dissolved in D2O to make aqueous solutions of EDTA and the pH was 
maintained at 7.2. For metalated samples, EDTA - Zn
2+
 aqueous solutions were prepared with 60 
mM of EDTA and 90 mM of ZnCl2. All the solutions of EDTA and EDTA- Zn
2+
 were degassed 
via the freeze thaw method for a minimum of three times to remove any oxygen present in our 
samples.   
13
C NMR relaxation measurements were performed at 25 
o
C, 40 
o
C, 50 
o
C.  A Bruker 400 MHz 
(B0 = 9.4 T) spectrometer at 100.6 MHz and a Varian 500 MHz (B0 = 11.7 T) spectrometer at 
125.2 MHz were used to carry out the measurements. The data was obtained using the inversion 
recovery method. Non-linear least square procedures were used for the analysis of T1 
measurements. The NOE factors were determined at 125.2 MHz by setting the decoupler on-
resonance and far off-resonance in successive experiments.   
Theory 
EDTA is a simple spin system with three carbon resonances appearing in EDTA at 175.7 ppm 
(carbonyl), 57.5 ppm (lateral), and 51.2 (central) while in the presence of Zn
2+
 the resonances 
shifted downfield to 178.1 ppm, 61.1 ppm, and 55.9 ppm respectively. Although there are four 
carbonyl carbons, two central, and four lateral carbons, only three resonances were observed in 
the spectrum (in the presence and absence of Zn
2+
) this indicates they are all chemically 
equivalent on the NMR time scale. Although the EDTA- Zn
2+
 complex forces the carbons to 
become chemically inequivalent, this is not observed in the spectrum, indicating that there may 
be a rapid inter-conversion of the carbonyl groups coordinating Zn
2+
. 
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The carbonyl carbon’s spin lattice relaxation mechanism is known to relax via the chemical shift 
anisotropy ( CSA
1R ) and spin rotation pathways (
SR
1R ); as given in equation (7): 
  SR1
CSA
11 RRR   (7) 
Under extreme narrowing conditions and assuming a symmetric shielding tensor, the chemical 
shift anisotropy is given by equation (8): 
  C
2
O
2CSA
1 B
15
2
R  





  (8) 
In eqn. (8), γ is the carbon magnetogyric ratio, Bo is the field strength,   is the shielding 
anisotropy (132 ppm in EDTA and 119 ppm in EDTA/Zn
2+
 solution) (87)  and τc is the 
reorientational correlation time.  The spin rotation interaction is given as 
  J
 2
2
SR
1 C
h
IkT8
R 





  (9) 
where I is the moment of inertial, C is the spin rotation coupling constant, τJ is the angular 
momentum correlation time (i.e., time between molecular collisions),  k is the Boltzman 
constant, T is temperature in K, and h is Planck’s constant. A full analysis of angular momentum 
correlation time, through the spin rotation interaction, requires knowledge of the spin rotation 
coupling constant which is presently unavailable.  However, by combining equations (7) and (8), 
one sees a method by which the SR and CSA contributions can be separated experimentally. This 
method requires the measurement of the overall relaxation rate on multiple instruments operating 
at different field strengths; ∆BO. 
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A linear fit of R1 versus ∆BO will yield the reorientational correlation time from the slope.  The 
SR contribution can be deduced from either the intercept and/or from the difference between R1 
and CSA
1R .   
Calculation of Activation energies: 
Activation energy of the three carbons in EDTA is calculated before and after Zn
2+
 addition 
using the Arrhenius equation.  
                   (11) 
k is the rate constant, A is pre-exponential factor, Ea is the activation energy, and R is the 
universal gas constant. Taking the logarithm on both sides yields the equation above in the form 
of the equation of a straight line (y = mx+b): 
      
  
  
      
   (12) 
and all the variables can be found: y = lnk, m(slope) = -Ea/R, x = 1/T, and b = lnA 
An Arrhenius plot of τC (y-variable) versus T
-1 (x-variable) gives a negative slope from which 
activation energies will be obtained using the equation 
                               (13) 
Where R is the gas constant (8.3 J/mol*K) 
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These experiments will reveal if the changes in relaxation time are large enough for us to 
measure and thus tell if Zn
2+
 binding is taking place and will stand as a strong proof of principle 
to study Zn
2+
 binding in Protα. 
Results  
The various relaxation contributions of the carbonyl carbons along with the reorientational times 
are given in Tables 5.1 and 5.2. 
Table 5.1 shows the variable temperature relaxation rates (R1), the chemical shift anisotropy (
CSA
1R ) and spin rotation (
SR
1R ) contributions as well as the correlation times (τC) calculated via 
equation (7) of the carbonyl carbon of EDTA in the absence of Zn
2+
.  As expected, these rates 
are seen to decrease with rising temperature indicating a decrease in the effectiveness of the 
dominating mechanism; CSA.  The SR mechanism displays the opposite trend; increasing with 
rising temperature. The last column of this table contains the values for the correlation times 
obtained via the CSA contribution and equation (8).  The correlation times, τC, are seen to 
decrease with rising temperature indicating faster molecular dynamics at the carbonyl site with 
increasing temperature. 
Table 5.2 lists the same variable temperature data but with the addition of Zn
2+
 to the solution.  A 
comparison of the relaxation rates from these two tables reveals that the introduction of Zn
2+
 to 
the solution does affect the relaxation rates of the carbonyl carbon appreciably. One notices an 
increase in the overall relaxation rate and a similar tendency for the CSA contribution.  At the 
lower field strength, the data show the SR mechanism dominates at 323K.   A comparison of the 
correlation times in Tables 5.1 and 5.2 indicate that the presence of Zn
2+
 does lead to noticeable 
reduction of the molecular dynamics at the carbonyl site indicating intermolecular interactions at 
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this site with Zn
2+
.  This observation is further supported by the differences in the activation 
energies at this site.  An Arrhenius fit of τc versus T
-1
 yielded energies of activation of 33.7 and 
40.3 kJ/mole without and with Zn
2+
, respectively; suggesting the 6.7 kJ/mol energy difference is 
due to the presence of intermolecular interactions between Zn
2+
 and the carbonyl sites. 
 
Figure 5.8: Arrhenius plot of carbonyl carbon in EDTA with and without Zn
2+
. The slopes were 
used to calculate activation energies. 
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Table 5.1 Spin Lattice relaxation rates, CSA and SR contributions, and correlation times of the carbonyl 
carbon of EDTA at different field strengths and as a function of temperature. 
   T(K)          Bo(MHz)         R1(1/s)              R1
(CSA)
(1/s)         R1
(SR)
 (1/s)     %CSA            %SR       τC (ps) 
 298           125.2              0.175               0.150              0.025             85.7          14.3    105 
                  100.6             0.104               0.082              0.022             78.8          21.2  
 313           125.2             0.113               0.088              0.025             77.9          22.1    61 
  100.6            0.081               0.056              0.025             69.1          30.9 
 323 125.2            0.087               0.053              0.034             60.9          39.1   36 
  100.6            0.068               0.034              0.034             50.0          50.0 
 
 
 
 
 
      
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
131 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.2: Spin Lattice relaxation rates, CSA and SR contributions, and correlation times of the 
carbonyl carbon of EDTA with Zn
2+
 at different field strengths and as a function of temperature  
T(K)        Bo(MHz)      R1(1/s)       R1
(CSA) 
(1/s)         R1
(SR) (1/s)       %CSA       %SR       τC (ps) 
298           125.2        0.214         0.195          0.019      91.1 8.9        165 
             100.6        0.130         0.111          0.019      85.4 14.6  
313          125.2        0.135         0.129          0.006      95.6 4.4         110 
             100.6        0.089         0.083          0.006      93.3 6.7 
323           125.2       0.094         0.051          0.043      54.3           45.7        44 
             100.6       0.076        0.033          0.043      43.4          56.6 
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Section 5.4 Relaxation rates of the lateral and central carbons 
Theory  
The lateral and central carbons possess two hydrogens each which will lead to dipole-dipole 
interactions.  The spin lattice relaxation rate of these two carbons proceeds primarily via the 
dipole-dipole ( DD
1R ) and spin rotation (
SR
1R ) mechanisms. 
  SR1
DD
11 RRR   (14) 
The dipole-dipole contribution can be experimentally isolated through the use of NOE 
measurements and equation (15): 
  1
NOEDD
1 R
1.987
R

  (15) 
The spin rotation contribution is given by equation (5) but can be obtained from the difference 
between R1 and
DD
1R .  The 
DD
1R and 
SR
1R relaxation contributions for the lateral and central 
carbons, along with the re-orientational correlation times, are given in Tables 5.3 and 5.4. 
Results and discussion 
Table 5.3 lists the overall spin lattice relaxation rates (R1) of the lateral and central carbons, the 
NOE values ( NOE ), the dipole-dipole (
DDR1 ) and spin rotation (
SRR1 ) contributions as well as the 
correlation times (τc) at these two sites.  This table illustrates the overall relaxation rates decrease 
only slightly with rising temperature with the dipole-dipole mechanism dominating at all 
temperatures. As anticipated, the spin rotation contribution gradually increases with rising 
temperature. The final column in this table lists the correlation times which provide a glimpse of 
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the dynamics at these two sites.  One sees a larger increase in the reorientational motion of the 
lateral carbon with rising temperature as compared to the central carbon.  An Arrhenius fit of the 
correlation times versus T
-1
 yielded energies of activation of 22.1 and 9.7 kJ/mole for the lateral 
and central carbons, respectively. These activation energies indicate greater rotational freedom at 
the central versus the lateral carbon site. 
The experimental spin lattice relaxation rates (R1), the NOE values ( NOE ), the dipole-dipole (
DDR1 ) and spin rotation (
SRR1 ) contributions as well as the correlation times (τc) of the lateral and 
central carbons upon the introduction of Zn
2+
 to the EDTA solution are found in Table 5.4.  The 
data in this table illustrate a more dramatic change in all the experimental observables with the 
introduction of Zn
2+
 to the solution.  In particular, the overall relaxation rates of the lateral 
carbon experience larger changes with increasing temperature.  In fact, and surprisingly, the 
dipole-dipole mechanism becomes less efficient than spin rotation at all temperatures for this 
lateral carbon suggesting an increase in the re-orientational motion at this carbon site which is 
supported by the reduction of τc values with the introduction of Zn
2+
. This observation is 
conceivable if EDTA and Zn
2+
 interactions are simultaneously occurring at the carbonyl and –
CH2-N- (central site) resulting in enhanced rotational freedom (i.e. “quasi” free spinning) at the 
lateral methylene carbon site.  An Arrhenius fit of this carbon’s correlation times versus T-1 
yielded an energy of activation of 20.4 kJ/mole; approximately 2.0 kJ/mol less than without the 
presence of Zn
2+
. 
The overall relaxation rate of the central methylene group decreases incrementally with rising 
temperature with the dipole-dipole mechanism dominating at all temperatures.  A comparison of 
the correlation times, without (Table 5.3) and with Zn
2+
 (Table 5.4), shows a slowing of the 
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reorientational motion of this methylene group upon the introduction of the Zn
2+
 ion.  The τc data 
indicate the presence of intermolecular interactions between Zn
2+ 
and these –CH2-N- sites.  The 
Arrhenius fit of the central carbon’s correlation times versus T-1 yield activation energy of 11.4 
kJ/mole. One sees an increase of 1.7 kJ/mol in the activation energy upon the introduction Zn
2+
 
to the solution indicating the presence of intermolecular interactions at the –CH2-N- sites. 
 
 
Figure 5.9: Arrhenius plot of lateral carbon in EDTA with and without Zn
2+
. The slopes were 
used to calculate activation energies. 
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Figure 5.10: Arrhenius plot of central carbon in EDTA with and without Zn
2+
 showing the 
slope. The slopes were used to calculate activation energies. 
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Table 5.3 Spin Lattice relaxation rates, NOE, dipole-dipole and spin rotation contributions, and 
correlation times of the lateral and central carbons of EDTA as a function of temperature at 125.2 
MHz (11.7 T). 
T(K)       carbon        R1(1/s)         ᵑNOE        R1DD(1/s)        R1SR(1/s)     %D      %SR          τC (ps) 
298        Lateral         2.94          1.57           2.32              0.62           78.9              21.1          54 
          Central        2.94          1.22            1.80              1.14           61.2      38.8          42 
313       Lateral          2.04         1.51            1.55              0.49           76.0       24.0         36 
          Central        2.04          1.49            1.53              0.51           75.0       25.0         35 
323        Lateral        1.61          1.44            1.17              0.44           72.7       27.3         27 
          Central        2.00          1.33            1.34              0.66           67.0       33.0         31 
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Table 5.4: Spin Lattice relaxation rates, NOE, dipole-dipole and spin rotation contributions, and correlation 
times of lateral and central carbons of EDTA with Zn
2+
 as a function of temperature at 125.2 MHz (11.7 T). 
T(K)      carbon     R1(1/s)     ᵑNOE      R1(DD)(1/s)       R1(SR) (1/s)    %DD       %SR         τC (ps) 
298       Lateral      3.13     0.24            0.37             2.76           11.8        88.2          8.6 
            Central      4.00     1.19           2.40              1.60           60.0        40.0          56 
313       Lateral      1.30     0.35           0.23              1.07            17.7         82.3         5.4 
             Central      3.23    1.21            1.97              1.26            61.0         39.0          46 
323       Lateral      0.73    0.54            0.20              0.53             27.4         72.6         4.6 
             Central     1.96    1.71            1.68              0.28             84.8         15.2          39 
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Section 5.5 Conclusions 
 
The study was undertaken to explore the effectiveness of spin inversion recovery experiments to 
detect Zn binding in Protα. EDTA and Zn complexes were originally chosen because of the 
structural similarity of EDTA to the carboxylate group of aspartic and glutamic acid, which are 
the plausible ligands of Zn in Protα(50-89)N50W. The general conclusion from our work is that 
a difference in the relaxation times was successfully detected in the EDTA samples with and 
without Zn, thus providing a proof of principle to carry out Zn binding study on Protα(50-
89)N50W or other acidic sequences. It should be noted that in order to get residue level 
information peptides will require 
13
C labeling.   
To get into more details about the work, spin lattice relaxation measurements conducted on 
EDTA/D2O solutions as well as EDTA/Zn
2+
/D2O solutions as a function of field strength and 
temperature were used to calculate the contribution of different relaxation methods (CSA, SR, 
DD) and correlation times. These measurements showed that the chemical shift anisotropy 
mechanism is the dominating mechanism in the carbonyl carbon relaxation process.  A 
comparison of the correlation times in solutions containing Zn
2+
 and without Zn
2+
 showed the 
presence of intermolecular interactions at these sites.  Surprisingly, our results show that the 
lateral methylene groups increase their reorientational motion upon the introduction of Zn
2+
 to 
the solution suggesting the anchoring of the carbonyl and the central methylene sites give rise to 
increased reorientational freedom at the lateral methylene sites. 
The results obtained here coincide well with a previous study of EDTA and Zn carried out at pH 
12.0 (87). In both the studies there was an increase in the correlation times of central and 
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carbonyl carbon before and after Zn addition. However, the lateral carbon showed a decrease in 
correlation times in the presence of Zn (compared to the no Zn sample) which deviates from the 
previous study.  This could be due to the difference in the pH in the two studies. At pH 12.0 all 
the carboxyl groups remain deprotonated and can bind Zn more strongly whereas at pH 7.4 the 
carboxyl groups of EDTA may only be partially deprotonated potentially allowing for exchange 
of the carboxylate groups between the axial and equatorial positions causing the difference in the 
correlation times. This study tells us the depth of information that can be obtained for Zn binding 
in Protα(50-89)N50W.  
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Chapter 6 Conclusions and Future Studies 
 
The central research question presented here is to understand if natively unfolded proteins bind 
metals like folded proteins that being with a well-defined set of ligands, or if there is more 
heterogeneity in ligand set used. Protα is a natively unfolded protein that binds metal cations but 
undergoes structural rearrangement only in the presence of Zn
2+
. Zn
2+
 binding in Protα was taken 
as a case study to understand metal binding in natively unfolded proteins.  
The following research questions have been addressed in our research to contribute in the 
investigation of Zn
2+
 binding region of Protα.  
1.1 Develop a synthetic method using 4-pyridinemethanol as a side chain protecting group on 
Asp and Glu to improve the synthesis, purification, and characterization of highly negatively 
charged sequences. 
1.2 Determine the structural changes in the central segment of Protα in the presence of 
environmental factors like Zn
2+
 and temperature. 
1.3 Investigate the structural changes in the Protα(50-89)N50W using differential scanning 
calorimetry (DSC). 
1.4 Further refine the map of the Zinc binding region of Protα. 
The results obtained for each of these questions have been summarized below. 
The 4-pyridinemethanol protected aspartic and glutamic acid were developed to aid in the 
synthesis, purification, and characterization of central metal binding 50-89 region of Protα. Use 
of this protecting group in conjunction with benzyl ester side chain protection allows for acidic 
peptides to be separated using RP HPLC and characterized by positive ion mode ESI-MS. CD 
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studies have shown that majority of the Zn
2+
 binding occurs in the 50-89 region and that the 
major structural changes occur in this region. CD data has also shown that the peptide attains a 
secondary structure upon heating from 20–80 oC. DSC data also showed that the peptide 
undergoes an exothermic event upon heating suggesting an increase in structure which supports 
the temperature data obtained from CD. NMR studies on EDTA and Zn
2+
 studies have shown the 
effectiveness of 
13
C relaxation as a means to detect direct metal coordination.  
Significance:  
Difficult syntheses, such as that of ProTα(48-110), may now be feasible by a linear synthesis 
with use of an OMePyr protecting strategy. This allows researchers to study a larger variety of 
potential systems and can allow one to synthesize isotopically labeled peptides. It is important to 
have very robust synthetic methods to make these as isotopes are expensive. The fact that a 
highly charged sequence like ProTα(50-89) can selectively bind Zn2+ and becomes ordered when 
it does so provides insight into general metalloprotein design principles. Specifically, this can be 
used for selective disorder-to-order transitions which may serve a biological purpose such as 
enhancing binding to a partner (e.g. Rev or CREB). Thus, metal binding can be used as an on/off 
signal for proteins like ProTα.  
Limitations: 
1. The 4-pyridinemethanol protected aspartic and glutamic acid were not applied in the 
synthesis of Protα(50-89)N50W segment. Application of the group in model peptide has 
shown how the new protecting group performs in peptide synthesis protocols. However, 
long synthesis, purification, and characterization of long acidic sequences has always 
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been challenging and there is still a need to look at the performance of the new protecting 
group in the synthesis, purification and characterization of long peptide sequences.  
2. Although the data obtained from the secondary structural changes in Protα(50-89)N50W 
studied on CD and DSC by adding Zn
2+
 and varying temperature is informative, 
additional experiments that help us obtain more thermodynamic information are required 
to understand the details of temperature induced structural changes and to get a deeper 
insight into why the thermogram of Zn
2+
 added peptide showed a broader exothermic 
event compared to the no Zn
2+
 sample. 
To overcome these limitations the future work on this project should be focused on synthesizing 
the 50-89 sequence of Protα using 4-pyridinemethanol protected aspartic and glutamic acid.  In 
terms of building a thermodynamic profile of temperature induced structural changes in the 
peptide with and without Zn
2+
 added, an NMR study measuring the spin-lattice relaxation times 
(T1) would be helpful. From the relaxation measurements and 
13
C labeling studies one could also 
address the question if Zn
2+
 binding in Protα occurs at a specific site or if several degenerate sites 
exist.  
Relaxation measurements with selective 
13
C isotope labeling of carboxyl groups in aspartic and 
glutamic acid is the next step to investigate Zn
2+
 binding in Protα. Aspartic and glutamic acid 
will be selectively labeled with 
13
C isotope and a series of 
13
C NMR spectra will be collected 
using the inversion recovery method. Through creation of a series of selectively 
13
C labeled 
peptides, these studies will show if Zn
2+
 binding occurs to specific set of residues or if several 
degenerate sites exist. The existence of degenerate metal binding sites in at least two other IDPs 
has been noted (163, 164) and if this finding bears out in Prot it would suggest this may be a 
general feature of metallo-IDPs. 
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Chapter 7 Materials and Methods 
 
Materials for peptide synthesis  
Rink amide MBHA resin, HBTU, HOBt and Fmoc-amino acids were purchased from EMD 
Millipore. N,N-Diisopropylethylamine (DIEA), triisopropylsilane (TIS), 4-pyridinemethanol, and 
Pd/C were obtained from Sigma-Aldrich. Both N,N-dimethylformamide (DMF) and 
trifluoroacetic acid (TFA) were purchased from Fisher Scientific.  
Methods for model peptide synthesis using 4-pyridylmethyl esters (161) 
Peptides were synthesized using a Protein Technologies Inc. PS3 peptide synthesizer.  All the 
peptides were synthesized on the 0.1 mmol scale using Rink amide MBHA resin with 0.3 
mmol/g substitution.  Upon cleavage, the peptide produced from this resin was C-terminal 
amidated.  Coupling of each amino acid was carried out in DMF using 4 equiv Fmoc-amino 
acid/HBTU/HOBt and 4 equiv DIEA with a 1 h coupling time.  When compounds 3a or 3b were 
incorporated into a peptide 2 equiv of Fmoc-amino acid/HBTU/HOBt were used. The Fmoc 
group was removed using 20% v/v piperidine in DMF with a reaction time of 30 min.  The final 
peptide was acetylated using 2 mL of acetic anhydride and 4 equiv DIEA in DMF.  
After synthesis the resin was washed with dichloromethane, methanol and then dried.  The resin 
was dried for 2 minutes using vacuum. The dried resin was treated with a TFA/TIS/H2O 
(95/2.5/2.5) solution for 2 h. After 2 hours the reaction mixture was filtered and the peptide 
precipitated with cold diethyl ether.  The precipitate was collected, dissolved in water and freeze 
dried.  The peptide was purified and characterized by RPHPLC and ESI-MS respectively and 
mass of the dried peptide was obtained to calculate percentage yields.   
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Purification by HPLC 
Peptides were purified on a Vydac C18 column (5 m, 4.6 x 250 mm) using a BioRad HPLC 
system. Crude peptides were purified using 0.1% TFA in water (Buffer A) and 0.1% TFA in 
acetonitrile (Buffer B).  After injection, isocratic elution at 100% Buffer A was run for 3 min. 
followed by gradient elution from 100% Buffer A to 0% Buffer A in 37 min. with a flow rate of 
1.0 mL/min.  Peptide signals were detected at both 214 nm and 280 nm. 
Characterization 
All peptides were characterized by ESI-MS after elution from HPLC, and thus were dissolved in 
water/acetonitrile containing 0.1% TFA.  Sample was delivered to the ESI source with a KD 
Scientific syringe pump at 10 μL/min, and the electric potential used to initiate ESI (i.e. capillary 
voltage) was 2500 V.  The source temperature was set at 90 °C and the desolvation temperature 
at 275 
o
C with a cone gas flow of 10 L/h and a desolvation gas flow of 500 L/h. 
Hydrogenation 
The peptide was dissolved in 10 mL of ethyl acetate and 2 mg of 5% Pd/C was added.  The 
reaction flask was placed under a hydrogen atmosphere of 70 psi and shaken overnight using a 
Parr hydrogenator.  The Pd/C catalyst was removed by filtration through a fritted glass filter and 
the ethyl acetate was removed under reduced pressure. 
 
Materials for synthesis of Protα(50-89)N50W and Polyglutamic acid 
Rink Amide MBHA resin, HBTU, HOBt, and Fmoc-amino acids were purchased from 
NovaBioChem. N,N-diisopropylethylamine (DIEA) and triisopropylsilane were obtained from 
Aldrich. N,N-dimethylfomamide and trifluoroacetic acid were purchased from Fischer scientific. 
Protα(50-89)N50W and Polyglutamic acid were purified on a mono-Q 5/5 column using a 
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BioRad HPLC system. Slide-A-Lyzer cassettes with 3.5 kD MWCO with 0.5-3.0 mL and 4.0-
12.0 mL volumes were obtained from Pierce Biotechnology. 
Methods for synthesis of Protα(50-89)N50W and Polyglutamic acid  
Synthesis of Protα(50-89)N50W was performed manually using a CEM Discover 
Microwave Synthesizer. All the amino acids were assembled in a linear fashion on a 0.25 mmol 
scale using Rink Amide MBHA resin with 0.35 mmol/g substitution. All the Fmoc amino acids 
used in the synthesis were Fmoc protected at the N-terminal end and side chain protected where 
applicable. The Fmoc Protecting group was removed using 20% (v/v) solution of piperidine in 
DMF and the reaction time was for 3 minutes. Coupling reactions were performed in DMF by in 
situ activation of a 4 equivalent excess of Fmoc-amino acid using 8 equivalents excess of 
HBTU/HOBt/DIEA. Coupling times were for 5 minutes for all the amino acids. After each 
coupling and deprotection step the resin was extensively rinsed with DMF and the completeness 
of these reactions was often tested using the ninhydrin test. The final peptide sequence was 
acetylated using acetic anhydride in DMF with 2.0 mmol DIEA.  
Synthesis of the Polyglutamic acid sequence was carried out on a PS3 synthesizer.  All the amino 
acids were arranged in a linear fashion on 0.1 mmol scale Rink Amide MBHA resin with 0.35 
mmol/g substitution. All the solvents used in the synthesis were the same as those used in 
microwave synthesis mentioned above. The coupling and deprotection times were usually 1.5 
hours and 30 min respectively for each amino acid unless the reaction was deemed incomplete. 
The Fmoc protecting group was removed from the amino acid by using 20% piperidine. The 
final peptide was acetylated using acetic anhydride in DMF with 2.0 mmol DIEA.  
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The glutamic acid residues used in the synthesis of Protα(50-89)N50W and Polyglutamic acid 
were tertiary butyl (tBu) protected. 
Upon on completion of synthesis of the target sequences, the resins from individual synthesis 
were washed with DMF, dichloromethane and methanol separately. They were dried for 2 
minutes using vacuum. Each peptide was cleaved from the resin in a solution of TIS/H2O/TFA 
(2.5/2.5/9.5) for 2 hours. After 2 hours the reaction mixture was collected and peptide was 
precipitated with cold diethyl ether. The precipitate was obtained as a pellet after centrifugation 
and decanting the supernatant. The crude peptide was dissolved in water, flash frozen and freeze 
dried.  
Purification by HPLC 
Protα(50-89)N50W and Polyglutamic acid were purified on a mono-Q 5/5 strong anion exchange 
(SAX) column using 20 mM glycine with 1M NaCl at pH 5.3 as buffer A and 20 mM glycine at 
pH 5.3 as buffer B. A gradient elution from 100% B to 0% B in 32 minutes was used and 
Protα(50-89)N50W and polyglutamic acid had a retention time of 18 minutes. 
Dialysis 
The peaks collected from SAX were dialyzed extensively to get rid of any sodium in the 
samples. The peptide samples were loaded into 2 kD MWCO dialysis cassettes (0.5 – 3.0 mL or 
4.0 – 12.0 mL capacities) and dialyzed against 1 L of 150 mM ammonium acetate three times for 
1 hour each, later dialyzed against 50 mM ammonium formate thrice for 1 hour each and against 
1 L of deionized water (18 MΏ cm-1, pH = 5.1) once for 2 hours. 
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Characterization 
Samples from Protα(50-89)N50W and Polyglutamic acid sequence were characterized on a 
Micromass Q-ToF Micro Mass Spectrometer in negative ion mode. Purified and dialyzed 
peptides were delivered to the ESI source with a KD scientific syringe pump at 10 μl/min, and 
the electric potential used to initiate ESI was 2600 V. The source conditions were optimized to 
provide best S/N ratio with lowest amount of fragmentation (facile losses of water). The source 
temperature was set at 50 
o
C. The nebulizer gas pressure was 25 psi and the dry gas flow rate 
was 10 mL/min. The capillary skimmer voltage difference was 88.5 V. 
CD Experiments 
50 mM Phosphate buffer 
Sodium biphosphate and sodium monophosphate were purchased from Sigma Aldrich. 18 mΩ-
cm water was used to make the buffer. The pH was adjusted to 7.2.  
Zn
2+
 studies  
CD spectra were obtained by acquiring 8 scans from 260 to 190 nm on a Jasco J-815  
spectrometer (equipped with Jasco SOFTWARE V) using a 1 mm pathlength quartz cell (Starna 
Cells, Atascadero, CA) at a speed of 20 nm/min, a 1 nm bandwidth, a data pitch of  0.2 nm, 
response time 0.25 sec and 5 mdeg sensitivity at room temperature (~25 ºC) in a continuous 
scanning mode. Contributions due to phosphate buffer were eliminated by subtracting the 
phosphate buffer spectrum from the peptide solutions.  All analysis of CD spectra were 
conducted after smoothing (Means-movement with convolution width of 5-25) and conversion to 
molar ellipticity using the JASCO Spectra Analysis program. 
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Table 7.1: Concentrations of the peptide and concentration and equivalents of Zn
2+
 used in Zn
2+
 
titrated CD runs 
Temperature studies 
CD spectra were obtained by acquiring 8 scans from 260 to 190 nm on a Jasco J-815 
spectrometer (equipped with Jasco SOFTWARE V) equipped with temperature cell holder using 
a 0.1 mm pathlength cylindrical quartz cell (Starna Cells, Atascadero, CA) at a speed of 20 
nm/min, a 1 nm bandwidth, a data pitch of  0.2 nm, response time 0.25 sec and 5 mdeg 
sensitivity in a temperature range of 20-80 
o
C in a continuous scanning mode. Contributions due 
to phosphate buffer were eliminated by subtracting the phosphate buffer spectrum from the 
Peptide 
Concentration 
(mM) 
ZnCl2 
Concentration 
(mM) 
Eq. of  Zn
2+
 in 
peptide sample 
0.5 0 0 
0.5 10 20 
0.5 17.5 35 
0.5 25 50 
0.5 37.5 75 
0.5 50 100 
0.5 75 150 
0.5 100 200 
 
 
149 
 
peptide solutions at respective temperatures. All analysis of CD spectra were conducted after 
smoothing (Means-movement with convolution width of 5-25) and conversion to molar 
ellipticity using the JASCO Spectra Analysis program. 
Modulated DSC Experiments 
Sample preparation for DSC studies  
                                           
Figure 7.1: T zero sample press and pans used to seal samples for DSC experiments. 
DSC experiments were carried out on TA Instruments Q2000 calorimeter. 50 mM phosphate 
buffer at pH 7.2 was used as a solvent to prepare peptide solutions. Prior to analysis the samples 
were centrifuged for 5 min. Protein concentration was maintained at 50 mg/ml. Thermograms 
were collected on a 10 µl sample of Protα(50-89)N50W with and without Zn2+ in a hermetically 
sealed t-zero aluminium pans, at a scan rate of 1
o
C/min from 25 to 80 
o
C under modulated 
conditions. Data was analyzed using universal analysis (TA instruments), to determine the 
melting temperature (Tm) and enthalpy (∆H) associated with the thermal events in Protα peptide 
in the presence of Zn
2+
, using a horizontal baseline. 
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EDTA and Zn
2+
 studies  
Materials 
Ethylenediaminetetraacetic acid disodium salt dehydrate, D2O, and ZnCl2 were purchased from 
Sigma aldrich (>99%).  
Methods  
60 mM of the salt was dissolved in D2O to make aqueous solutions of EDTA. EDTA- Zn
2+
 
aqueous solution was prepared with 60 mM of EDTA and 90 mM of ZnCl2. The pH of both the 
solutions was maintained at 7.2.  All the solutions of EDTA and EDTA- Zn
2+
 were degassed via 
the freeze thaw method for a minimum of three times to remove any oxygen present in our 
samples. 
NMR measurements 
13
C NMR relaxation measurements were performed at 25 
0
C, 40 
0
C, 50 
0
C.  Bruker 400 MHz 
(B0=9.4 T) spectrometer at 100.6 MHz and Varian 500 MHz (B0 =11.7 T) spectrometer at 125.2 
MHz were used to carry out the measurements. The data was obtained using Inversion recovery 
method. Non-linear least square procedures were used for the analysis of T1 measurements. The 
NOE factors were determined at 125.2 MHz by setting the decoupler on-resonance and far off-
resonance in successive experiments.   
Freeze thaw procedure 
The sample was placed in the NMR tube shown above to which a ground glass joint had been 
attached. The tube is then attached to a vacuum manifold and the sample was frozen using liquid 
nitrogen. 
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Figure 7.2:  NMR sample tubes used to seal the sample by freeze thaw procedure. A) Sample 
tube before sealing B) sample tube after sealing. 
After freezing the sample it was pumped on for 1 min and allowed to thaw slowly under its own 
vapor pressure. The procedure was repeated at least 2 more times. The process is tricky because 
if the liquid nitrogen touches the NMR tube it might break. So the sample should be frozen using 
liquid nitrogen yet not bringing into contact with it. 
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Chapter 8 
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